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A B S T R A C T
Background
This is an update of a Cochrane Review published in 2014. Chronic non-specific low back pain (LBP) has become one of the main causes
of disability in the adult population around the world. Although therapeutic ultrasound is not recommended in recent clinical guidelines,
it is frequently used by physiotherapists in the treatment of chronic LBP.
Objectives
The objective of this review was to determine the eMectiveness of therapeutic ultrasound in the management of chronic non-specific LBP.
A secondary objective was to determine the most eMective dosage and intensity of therapeutic ultrasound for chronic LBP.
Search methods
We performed electronic searches in CENTRAL, MEDLINE, Embase, CINAHL, PEDro, Index to Chiropractic Literature, and two trials registers
to 7 January 2020. We checked the reference lists of eligible studies and relevant systematic reviews and performed forward citation
searching.
Selection criteria
We included randomised controlled trials (RCTs) on therapeutic ultrasound for chronic non-specific LBP. We compared ultrasound (either
alone or in combination with another treatment) with placebo or other interventions for chronic LBP.
Data collection and analysis
Two review authors independently assessed the risk of bias of each trial and extracted the data. We performed a meta-analysis when
suMicient clinical and statistical homogeneity existed. We determined the certainty of the evidence for each comparison using the GRADE
approach.
Main results
We included 10 RCTs involving a total of 1025 participants with chronic LBP. The included studies were carried out in secondary care settings
in Turkey, Iran, Saudi Arabia, Croatia, the UK, and the USA, and most applied therapeutic ultrasound in addition to another treatment, for
six to 18 treatment sessions. The risk of bias was unclear in most studies. Eight studies (80%) had unclear or high risk of selection bias; no
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studies blinded care providers to the intervention; and only five studies (50%) blinded participants. There was a risk of selective reporting
in eight studies (80%), and no studies adequately assessed compliance with the intervention.
There was very low-certainty evidence (downgraded for imprecision, inconsistency, and limitations in design) of little to no diMerence
between therapeutic ultrasound and placebo for short-term pain improvement (mean diMerence (MD) −7.12, 95% confidence interval (CI)
−17.99 to 3.75; n = 121, 3 RCTs; 0-to-100-point visual analogue scale (VAS)). There was also moderate-certainty evidence (downgraded for
imprecision) of little to no diMerence in the number of participants achieving a 30% reduction in pain in the short term (risk ratio 1.08, 95%
CI 0.81 to 1.44; n = 225, 1 RCT). There was low-certainty evidence (downgraded for imprecision and limitations in design) that therapeutic
ultrasound has a small eMect on back-specific function compared with placebo in the short term (standardised mean diMerence −0.29,
95% CI −0.51 to −0.07 (MD −1.07, 95% CI −1.89 to −0.26; Roland Morris Disability Questionnaire); n = 325; 4 RCTs), but this eMect does not
appear to be clinically important. There was moderate-certainty evidence (downgraded for imprecision) of little to no diMerence between
therapeutic ultrasound and placebo on well-being (MD −2.71, 95% CI −9.85 to 4.44; n = 267, 2 RCTs; general health subscale of the 36-item
Short Form Health Survey (SF-36)). Two studies (n = 486) reported on overall improvement and satisfaction between groups, and both
reported little to no diMerence between groups (low-certainty evidence, downgraded for serious imprecision). One study (n = 225) reported
on adverse events and did not identify any adverse events related to the intervention (low-certainty evidence, downgraded for serious
imprecision). No study reported on disability for this comparison.
We do not know whether therapeutic ultrasound in addition to exercise results in better outcomes than exercise alone because the certainty
of the evidence for all outcomes was very low (downgraded for imprecision and serious limitations in design). The estimate eMect for pain
was in favour of the ultrasound plus exercise group (MD −21.1, 95% CI −27.6 to −14.5; n = 70, 2 RCTs; 0-to-100-point VAS) at short term.
Regarding back-specific function (MD − 0.41, 95% CI −3.14 to 2.32; n = 79, 2 RCTs; Oswestry Disability Questionnaire) and well-being (MD
−2.50, 95% CI −9.53 to 4.53; n = 79, 2 RCTs; general health subscale of the SF-36), there was little to no diMerence between groups at short
term. No studies reported on the number of participants achieving a 30% reduction in pain, patient satisfaction, disability, or adverse
events for this comparison.
Authors' conclusions
The evidence from this systematic review is uncertain regarding the eMect of therapeutic ultrasound on pain in individuals with chronic
non-specific LBP. Whilst there is some evidence that therapeutic ultrasound may have a small eMect on improving low back function in
the short term compared to placebo, the certainty of evidence is very low. The true eMect is likely to be substantially diMerent. There are
few high-quality randomised trials, and the available trials were very small. The current evidence does not support the use of therapeutic
ultrasound in the management of chronic LBP.
P L A I N   L A N G U A G E   S U M M A R Y
Ultrasound therapy for chronic low back pain
Background
It is common for people to feel pain in their lower back. When the cause of pain is unknown, we say that the pain is ‘non-specific’. Pain that
lasts for more than three months is considered to be 'chronic'.
Chronic non-specific low back pain can be disabling. It can cause people to miss work. OSen, people with chronic non-specific back pain
seek medical care.
Ultrasound therapy is the use of sound waves (vibrations) to treat medical problems. It is commonly used to treat low back pain. A
healthcare provider rubs a hand-held machine against the skin on the lower back. The machine produces vibrations that go through the
skin. The aim is to deliver heat and energy to body parts under the skin, to reduce pain and speed up recovery.
This Cochrane Review aimed to find out whether ultrasound is eMective for treating chronic non-specific low back pain, and whether it
causes any unwanted eMects. Specifically, we wanted to know if ultrasound aMected the following outcomes: pain, people feeling restricted
in their daily life by pain, satisfaction with the treatment, well-being, disability, and other unwanted eMects.
What did we look for?
We looked for studies published up to January 2020 that:
• were randomised controlled trials, medical studies where people are randomly put into one of two or more treatment groups. This type
of study provides the most reliable evidence about whether a treatment makes a diMerence;
• included people with chronic non-specific low back pain who were aged 18 years or older;
• compared ultrasound (either alone or with another treatment) with a placebo (fake treatment) or other treatments for chronic non-
specific low back pain.
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What did we find?
We found 10 studies that included a total of 1025 people treated for chronic non-specific low back pain.
Most people in the studies had mild to moderate back pain, which means they may have found daily activities painful. They were treated
in outpatient hospital departments or clinics, where they typically had six to 18 sessions of ultrasound therapy. Study participants were
then followed for a period of time aSer the treatment (usually a few days or weeks).
Studies compared ultrasound to one or more of the following: placebo (five studies), no treatment (one study), electrical pulses (one study),
manipulation of the spine (one study), osteopathy (one study), and laser therapy (one study). Three studies compared ultrasound with
exercise to exercise alone. None of the studies was commercially funded.
Key results
There is little to suggest that ultrasound is an eMective treatment for people with non-specific chronic low back pain.
Ultrasound compared with placebo
We do not know whether ultrasound reduces average pain intensity because this has been studied in too few people, in studies that gave
varying answers and were poorly conducted. Ultrasound probably makes little or no diMerence to the number of people in whom pain is
reduced by 30% or more in the short term (i.e. less than three months aSer the start of the study).
Ultrasound probably makes little or no diMerence to people’s well-being. It may make little or no diMerence to how much people feel
restricted by their back pain in daily life, or to how satisfied people are with their treatment.
Ultrasound may have little or no impact on unwanted eMects. We do not know whether ultrasound aMects disability since no studies
investigated this.
Ultrasound with exercise compared with exercise alone
We do not know whether ultrasound aMects the outcomes of interest in this review because either no studies investigated them, or because
the studies that did were imprecise or poorly conducted.
Certainty of the evidence
Based on the studies we found, there was mostly low- to very low-certainty evidence that ultrasound makes little or no diMerence to pain
and well-being compared to placebo. For all the other outcomes and comparisons, we are less confident in the results we reported. This
is because studies were too imprecise or were poorly conducted.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Therapeutic ultrasound versus placebo
Therapeutic ultrasound compared to placebo for chronic low back pain




Illustrative comparative risks (95% CI)


















Scale: VAS (100-point scale;
higher scores mean increased
pain)
Follow-up: short term (post-
treatment)
The mean pain intensity in the
control groups ranged from
30.7 to 78.9.
The mean pain intensity in the
intervention groups was 7.12











Estimate is not clinically im-
portant and is very uncertain.
Pain intensity
Scale: VAS (number of respon-
ders at 30% reduction of pain)
Follow-up: short term (post-
treatment)










Estimate is not clinically im-
portant and suggests there




Scale: Functional Rating Index,
Roland-Morris Disability Ques-
tionnaire, or Oswestry Disabili-
ty Questionnaire (higher scores
mean worse function)
*The mean Roland-Morris Dis-
ability Questionnaire score in
the control group for the most
representative study, Licciar-
done 2013, is 4 (SD 3.7).
The mean back-specific func-
tional status in the intervention
groups was 1.07 points lower
(1.89 lower to 0.26 lower) us-










Estimate is not clinically im-
portant and suggests there



































































































































Follow-up: short term (post-
treatment)
Overall improvement or satis-
faction
2 studies reported on this outcome but did not provide data in a
form that permitted pooling. Both studies reported no meaningful








Estimate is not clinically im-
portant and suggests there
may be little to no difference
between groups.
Well-being
Scale: general health subscale
of SF-36 (higher scores mean
worse well-being)
Follow-up: short term (post-
treatment)
The mean well-being scores in
the control groups ranged from
55.2 to 77.
The mean well-being score in
the intervention groups was










Estimate is not clinically im-
portant and suggests there
is probably little to no differ-
ence between groups.
Disability No trials were identified that reported on this outcome.
Adverse events 1 study measured adverse events following treatment and report-
ed a total of 7/118 (5.9%) adverse events in the ultrasound group
and 4/107 (3.7%) events in the placebo group (Licciardone 2013).
3 of these events (2 in ultrasound group, 1 in placebo group) were
considered to be serious adverse events, however none of the re-





Estimate is not clinically im-
portant and suggests there
may be little to no difference
between groups.
*Of the included trials for this outcome, we chose the study that was a combination of the most representative study population and the lowest risk of bias (Licciardone
2013). This figure represents the mean outcome in the control group of this particular study.
CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio; SD: standard deviation; SMD: standardised mean difference; VAS: visual ana-
logue scale
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate certainty: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low certainty: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low certainty: We are very uncertain about the estimate.
1Downgraded one level for imprecision due to small sample size.
2Downgraded one level for unexplained statistical inconsistency (I2 = 77%).
3Downgraded one level for limitations in study design, two studies with unclear selection bias.
4Downgraded two levels for serious imprecision, no data available for meta-analysis.




































































































































Summary of findings 2.   Therapeutic ultrasound plus exercise versus exercise alone
Therapeutic ultrasound plus exercise compared to exercise alone for chronic low back pain
Patient or population: adults with chronic low back pain
Settings: secondary care
Intervention: therapeutic ultrasound plus exercise
Comparison: exercise
Illustrative comparative risks (95% CI)
Assumed risk Corresponding risk
Outcomes

















Scale: VAS (100-point scale; higher scores
mean increased pain)
Follow-up: short term (post-treatment)
The mean pain intensi-
ty in the control groups
ranged from 28.3 to 30.5.
The mean pain intensity in the in-
tervention groups was 21.1 points











Estimate is not clini-
cally important and is
very uncertain. 1 study
did not provide data in
a form to permit pool-
ing.
Pain intensity
Scale: VAS (number of responders at 30%
reduction of pain)
No trials were identified that reported on this outcome.
Back-specific functional status
Scale: Oswestry Disability Questionnaire
(higher scores mean worse function)
Follow-up: short term (post-treatment)
The mean back-specific
functional status in the
control groups ranged
from 8.2% to 18%.
The mean back-specific functional
status in the intervention groups










Estimate is not clini-
cally important and is
very uncertain.
Overall improvement or satisfaction No trials were identified that reported on this outcome.
Well-being
Scale: general health subscale of SF-36
(higher scores mean worse well-being)
Follow-up: short term (post-treatment)
The mean well-being
scores in the control
groups ranged from 64.2
to 66.8.
The mean well-being score in the
intervention groups was 2.50










Estimate is not clini-



































































































































Disability No trials were identified that reported on this outcome.
Adverse events No trials were identified that reported on this outcome.
Abbreviations: CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; VAS: visual analogue scale
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate certainty: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low certainty: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low certainty: We are very uncertain about the estimate.
1Downgraded one level for imprecision, small sample size.
2Downgraded two levels for serious limitations in design; both included studies had a high risk of performance and detection bias and an unclear risk of selection bias.
3Downgraded two levels for serious imprecision; small sample size, and the resulting estimate had a wide 95% confidence interval which includes both potential harm and




































































Cochrane Database of Systematic Reviews
B A C K G R O U N D
Description of the condition
Low back pain (LBP) is the most frequent self-reported type of
musculoskeletal pain. It is oSen recurrent and has important
socioeconomic consequences. Estimates of the prevalence of
LBP vary considerably between studies and reach 33% for
point prevalence, 65% for one-year prevalence, and 84% for
lifetime prevalence (Henschke 2015). Chronic non-specific LBP
and its resulting disability have become an enormous health and
socioeconomic problem (Maher 2017).
Low back pain is defined as pain and discomfort in the lumbosacral
region, below the last rib and above the gluteal crease. According
to the recommended diagnostic triage, three types of LBP can be
defined: 1) non-specific LBP; 2) LBP with nerve root symptoms;
and 3) LBP resulting from serious pathology (e.g. malignancy,
fracture, ankylosing spondylitis). Non-specific LBP, in which there
is no recognised patho-anatomical cause, is usually a benign, self-
limiting condition. Using the traditional classification system, LBP
is also categorised according to its duration as acute (shorter than
six weeks), subacute (six to 12 weeks), and chronic (longer than 12
weeks) (Krismer 2007; Waddell 2004).
The main objectives of treatment for LBP are for the patient
to return to their desired level of activity and participation
and to prevent chronic complaints and recurrences (Bekkering
2003). The fact that there are many types of treatment for LBP,
each of which has multiple subcategories, is testament that no
single approach has been able to demonstrate its superiority
(Haldeman 2008). The evidence shows that the eMectiveness
of some interventions is supported (e.g. exercise) (Saragiotto
2016), whilst other interventions are not eMective for LBP (e.g.
traction) (Gay 2001; Wegner 2013). This situation makes it very
challenging for clinicians, policymakers, insurers, and patients to
make decisions regarding which treatment is the most appropriate
for chronic LBP.
Description of the intervention
Ultrasound is commonly used for musculoskeletal disorders
by health professionals such as physiotherapists, osteopaths,
chiropractors, and sports therapists. However, the eMectiveness of
ultrasound for musculoskeletal problems remains controversial.
Previous systematic reviews on the eMects of ultrasound therapy
for diMerent musculoskeletal disorders found that there are few
studies on this topic and that there is a dearth of evidence
regarding its usefulness in the treatment of shoulder disorders,
degenerative rheumatic disorders, and myofascial pain (Chou
2017). The evidence to determine the eMectiveness and safety of
ultrasound in low back pain is insuMicient (Qaseem 2017).
Therapeutic ultrasound is proposed to deliver energy to deep
tissue sites through ultrasonic waves, to produce increases in tissue
temperature or non-thermal physiologic changes (Allen 2006).
Unlike ultrasound for medical imaging (which transmits ultrasonic
waves and processes a returning echo to generate an image),
therapeutic ultrasound is a one-way energy delivery which uses a
crystal sound head to transmit acoustic waves at 1 or 3 MHz and at
amplitude densities between 0.1 W/cm2 and 3 W/cm2 (Allen 2006;
Robertson 2006).
Therapeutic ultrasound can be delivered in two modes, continuous
or pulsed. Continuous ultrasound involves the delivery of non-stop
ultrasonic waves throughout the treatment period, whilst in pulsed
ultrasound the delivery is intermittently interrupted (Robertson
2006). Continuous ultrasound is traditionally used for its thermal
eMects. Pulsed ultrasound is thought to minimise the thermal
eMects; however, it is not possible to truly isolate the thermal
and non-thermal eMects, as both eMects occur with ultrasound
application (Robertson 2006).
How the intervention might work
Ultrasound refers to vibrations that are essentially the same as
sound waves but of a higher frequency, beyond the range of human
hearing. Therapeutic ultrasound is assumed to have thermal and
mechanical eMects on the target tissue, which result in an increased
local metabolism, circulation, extensibility of connective tissue,
and tissue regeneration (Robertson 2006).
When acoustic energy is absorbed as it penetrates soS tissues, it
causes molecules to vibrate under repeated cycles of compression
waves and rarefaction waves. The higher the intensity of the
ultrasonic beam and the more continuous the emission of acoustic
waves, the more vigorous the molecular vibration or kinetic energy.
The more vigorous the microfriction, the more frictional heat is
generated in the tissue (Dyson 1976). Tissue heating is presumed
to enhance tissue cell metabolism, which in turn is believed to
promote soS-tissue healing. Tissue heating is clearly of value in
numerous clinical conditions, through mechanisms of pain relief
and improving tissue flexibility, but the evidence does not fully
support the use of ultrasound as an eMicient thermal intervention
(Watson 2008).
Historically, ultrasound has been widely employed for its thermal
eMects, but it has been argued more recently that the 'non-thermal'
eMects of this energy form are more eMective (Watson 2008). The
physical mechanisms thought to be involved in producing these
non-thermal eMects include cavitation and acoustic streaming
(micromassage). Cavitation is triggered by the absorption of
acoustic energy and begins when minute gas pockets that
infiltrate most biological fluids develop into microscopic bubbles,
thus causing cavities in these fluids and the surrounding soS
tissues. Under the sustained influence of acoustic radiation, these
microscopic bubbles expand and contract (pulsate or oscillate)
at the same carrier frequency at which the acoustic waves are
produced. Microstreaming is the minute flow of fluid in the vicinity
of the pulsating bubbles and is triggered by stable cavitation. These
two phenomena are proposed to cause increased cell permeability
and to aMect the course of cell growth, which in turn can improve
tissue healing (O'Brien 2007).
Why it is important to do this review
There remains little evidence to support the use of most passive
physical therapies, including ultrasound for low back pain (Chou
2017). The previous version of this review was the first to
evaluate the eMectiveness of therapeutic ultrasound for individuals
with chronic LBP (Ebadi 2011). The current version updates the
literature search as well as the review methods as per current
recommendations from Cochrane Back and Neck, Furlan 2015,
and the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
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O B J E C T I V E S
The objective of this review was to determine the eMectiveness of
therapeutic ultrasound in the management of chronic non-specific
low back pain (LBP). A secondary objective was to determine the
most eMective dosage and intensity of therapeutic ultrasound for
chronic LBP.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered only randomised controlled trials (RCTs), published
in any language, that evaluated the use of therapeutic ultrasound
as a treatment in people with chronic LBP for inclusion in this
systematic review. We only included studies with a follow-up longer
than one day.
Types of participants
We included studies if they recruited adult patients with chronic
non-specific LBP. We excluded studies of postoperative patients
and individuals in whom a specific cause for their LBP had been
determined (e.g. vertebral fracture, malignancy).
Types of interventions
We included all RCTs comparing ultrasound (either alone or in
combination with exercise) with placebo or other interventions
for chronic LBP. We excluded studies if ultrasound was one part
of a treatment package and if it was not possible to determine
the eMectiveness of ultrasound alone; for example, we did not
include a study that compared aerobic exercise + home exercise
with hot pack + ultrasound + TENS (transcutaneous electrical
nerve stimulation), but included a study comparing an exercise
programme with ultrasound to the same exercise programme
without ultrasound.
Types of outcome measures
Primary outcomes
Primary outcome measures were:
• symptoms (e.g. pain),
• back-specific functional status (e.g. measured with the Roland
Morris Questionnaire, Oswestry Disability Index),
• overall improvement or satisfaction with treatment,
• well-being (e.g. quality of life measured with the 36-item Short
Form Health Survey (SF-36), 12-item Short Form Health Survey
(SF-12), EuroQol)
• disability (e.g. ability to perform activities of daily living, return-
to-work status, work absenteeism) (Furlan 2015).
Adverse events were also assessed to determine harms associated
with therapeutic ultrasound.
Secondary outcomes
Secondary outcome measures included:
• lumbar range of motion
• muscle strength
• endurance
Timing of the outcome measures
We defined the timing of outcome measurements as short term
(postintervention or less than three months postrandomisation),
intermediate term (from three months to less than six months
postrandomisation), and long term (from six months to one year
postrandomisation).
Search methods for identification of studies
Electronic searches
The following databases were searched by Cochrane Back and Neck
to 7 January 2020 with no language restrictions.
• Cochrane Central Register of Controlled Trials (CENTRAL, the
Cochrane Library, to Issue 1, 2020), searched using CRS Web
• MEDLINE (Epub Ahead of Print, In-Process & Other Non-Indexed
Citations, Ovid MEDLINE Daily and Ovid MEDLINE) (OvidSP, 1946
to 7 January 2020)
• Embase (1980 to 2020)
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL/CINAHL Plus, 1981 to 7 January 2020)
• Physiotherapy Evidence Database (PEDro) (7 January 2020)
• Index to Chiropractic Literature (ICL) (7 January 2020)
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (clinicaltrials.gov) (7 January 2020)
• World Health Organization (WHO) International Clinical Trials
Registry Platform (ICTRP) (apps.who.int/trialsearch) (7 January
2020)
Search strategies are in line with Furlan 2015 methods guideline
and are shown in Appendix 1.
Searching other resources
To supplement the electronic search strategy, we screened
reference lists from relevant publications and reviews and used
Science Citation Index to perform citation tracking of the RCTs
identified by the first step. We also contacted experts in the field of
therapeutic ultrasound to identify other relevant articles that may
have been missed by the electronic search.
Data collection and analysis
Selection of studies
Two review authors (SE, NH) independently screened the titles
and abstracts of all retrieved studies to identify those that were
potentially relevant. Any disagreements over study selection were
resolved by discussions. We obtained the full texts of those studies
deemed potentially relevant, and assessed these for inclusion in
the review. In cases of disagreement, a third review author (MvT)
was consulted.
Data extraction and management
We used a standardised data extraction form to extract data
from the included papers. The extracted data included study
characteristics (e.g. country, recruitment modality, study funding,
risk of bias), participant characteristics (e.g. number of participants,
age, sex, severity of LBP), description of the experimental and
control interventions, co-interventions, duration of follow-up,
outcomes assessed, and results. The same two review authors (SE,
NH) who conducted the study selection independently extracted
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the data. Any disagreements were discussed and a third review
author (MvT) was consulted if necessary.
Assessment of risk of bias in included studies
Two review authors (SE, NH) independently assessed the risk of
bias in each included study using the updated Cochrane Back
and Neck Review Group criteria (Furlan 2015). The 13 criteria are
shown in Table 1, and the criteria for a judgement of 'yes' are
presented in Table 2. The criteria in both tables are based on the
criteria in the updated Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011). In cases of disagreement, a third
review author (MvT) was consulted. The study by the lead author
of this review, Ebadi 2012, was assessed by two researchers with
experience in low back pain research (see Acknowledgements). We
assessed risk of bias for the included studies for each ‘Risk of bias’
domain.
Measures of treatment e=ect
We analysed continuous outcomes by calculating the mean
diMerence (MD) in follow-up scores with 95% confidence intervals
(CI) when studies used the same outcome measure, or the
standardised mean diMerence (SMD) with 95% CI when studies
used diMerent outcome measures for the same construct. We
calculated the risk ratio (RR) as the eMect measure for dichotomous
outcomes. For each treatment comparison, an eMect size and a 95%
CI were calculated and displayed as forest plots. All analyses were
conducted in Review Manager 5 (Review Manager 2014).
Unit of analysis issues
In cases where a trial evaluated two or more interventions (plus
a control arm), two separate 'pair-wise' comparisons were made.
This was necessary to avoid including data for controls more than
once in the same comparison. In this case we divided the control
group into equal parts whilst assuming equal incidence in these
groups. Suitable multiple treatment arms were grouped (e.g. arms
that evaluated diMerent dosages of therapeutic ultrasound), whilst
irrelevant trial arms were excluded.
We considered cluster-RCTs and cross-over trials as eligible for
the review and planned to include them in the analyses along
with individually randomised studies. For cluster-RCTs, we planned
that estimates adjusted for the intracluster correlation would be
extracted and used in the meta-analysis. For cross-over trials, we
planned that estimates from paired analyses or from the first
treatment phases would be extracted where possible and used in
the meta-analysis. However, no cluster-RCTs or cross-over studies
were included in the review.
Dealing with missing data
In the case of missing data, we made multiple attempts to
contact the corresponding authors of the studies. Where data were
reported in a graph and not in a table or the text, we estimated
the means and standard deviations from them. Where standard
deviations were not reported, we planned to estimate these from
the confidence intervals or other measures of variance if possible. If
the standard deviations for follow-up measurements were missing,
we planned to use the standard deviation for that measure at
baseline for subsequent follow-up measurements. Finally, if no
measure of variation was reported anywhere in the text, we
would estimate the standard deviation based upon other studies
with a similar population and risk of bias. Standard deviations
were available for all included studies, and no missing data were
identified.
Assessment of heterogeneity
Prior to meta-analysis, we assessed clinical heterogeneity of the
included RCTs by considering whether the studies were similar in
setting, participants, interventions, and outcomes. We evaluated
methodological heterogeneity by examining the variability in study
design and risk of bias. Where studies within a comparison were
considered to be clinically and methodologically heterogenous,
we performed a random-eMects meta-analysis in order to account
for diMerences in the included studies in patient population
and application of the intervention. Following meta-analysis, we
inspected forest plots visually to detect heterogeneity. We assessed
statistical heterogeneity using the Chi2 test and the I2 statistic. We
considered an I2 from 0% to 40% to indicate that heterogeneity
might not be important; 30% to 60% moderate heterogeneity; 50%
to 90% substantial heterogeneity; and 75% to 100% considerable
heterogeneity.
Assessment of reporting biases
For each included study we attempted to identify the clinical
trial registration record and published protocol. Where these were
available, we compared the methods to those in the final published
report. Where the trial registration or protocol were not available,
this was noted in the Characteristics of included studies tables and
assessed as at unclear risk of bias.
Data synthesis
Where possible, we combined the outcome measures from the
individual RCTs through meta-analysis provided suMicient clinical
and methodological homogeneity existed between studies. Where
SMD was calculated, the estimates were re-expressed in the scale
of the most representative study and presented in the 'Summary of
findings' tables (Higgins 2011).
We used the GRADE approach to interpret findings (Schünemann
2017), and employed GRADEpro GDT, GRADEpro GDT, to import
data from Review Manager, Review Manager 2014, to create
'Summary of findings' tables. According to the GRADE approach,
the certainty of the evidence reflects the extent to which we
are confident that an estimate of the eMect is correct. Evidence
certainty for a specific outcome was based on the assessment of
five principal domains: 1) limitations in study design or execution
(i.e. risk of bias), 2) consistency of results, 3) directness of evidence
(i.e. generalisability), 4) precision (suMicient data with narrow
confidence intervals), and 5) other reasons such as publication bias
(Appendix 2). The review authors agreed on GRADE evidence ratings
following discussion and referral to the GRADE Handbook (GRADE
Handbook).
'Summary of findings'
We created 'Summary of findings' tables for two main comparisons:
therapeutic ultrasound compared to placebo (Summary of findings
1) and therapeutic ultrasound plus exercise compared to exercise
alone (Summary of findings 2). These tables provide outcome-
specific information at short-term follow-up concerning the overall
certainty of evidence from each included study in the comparison,
the magnitude of eMect of the interventions examined, and
the sum of available data on the following outcomes rated as
particularly important to patient care and decision-making: pain
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intensity, back-specific functional status, overall improvement or
satisfaction, well-being, disability, and adverse events.
Subgroup analysis and investigation of heterogeneity
A secondary objective of this review was to determine the most
eMective dosage and intensity of therapeutic ultrasound for chronic
LBP. Where a suMicient number of studies (i.e. > 10) were included
in a meta-analysis, we would perform subgroup analyses based on
dosage (W/cm2) and intensity (number and duration of treatment
sessions). We also planned to perform subgroup analyses to
determine the eMect of study methods, risk of bias, and clinical
diMerences. However, as only 10 studies were included in the
review, subgroup analyses were not performed.
Sensitivity analysis
We planned to perform sensitivity analyses to exclude studies at
high risk of selection and reporting bias from the analyses.
R E S U L T S
Description of studies
Results of the search
Our search strategy identified 2778 references from electronic
databases and 46 records from additional sources (Figure 1). ASer
removal of duplicates, 2824 unique articles were screened based
on title and abstract for potential relevance. We retrieved the full
texts of 66 trials deemed potentially relevant and screened these for
inclusion in the review. We checked the reference lists of previous
reviews on ultrasound but this did not result in the identification of
any further relevant studies. Two review authors (SE, NH) agreed on
the inclusion of five new trials for this update, which were added to
the five trials from the original review.
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Figure 1.   Study flow diagram.
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We classified four trials as awaiting assessment and one trial as an
ongoing study (for details, see Characteristics of studies awaiting
classification; Characteristics of ongoing studies).
Included studies
We included nine studies published in English and one Croatian
study (which was translated by a native speaker) in the review.
Outcome measures and intervention details are described below
as well as in the Characteristics of included studies table. The
10 included studies reported on a total of 1025 participants.
The included studies had mostly small sample sizes, with only
three studies having more than 25 participants per treatment
arm (Abdel-Aziem 2012; Licciardone 2013; Mohseni-Bandpei 2006).
All studies were performed in secondary care settings, usually
in outpatient physiotherapy departments. Three studies were
from Turkey (Durmus 2010a; Durmus 2010b; Durmus 2013); two
were from Iran (Ansari 2006; Ebadi 2012); two were from Saudi
Arabia (Abdel-Aziem 2012; Khan 2013); and one each were from
Croatia (Grubisic 2006), the UK (Mohseni-Bandpei 2006), and USA
(Licciardone 2013). No study reported a conflict of interest with
regard to funding.
One study with three arms compared ultrasound to no treatment
and electrical stimulation (Durmus 2010b); three studies compared
ultrasound plus exercise to exercise alone (Durmus 2010b; Durmus
2013; Khan 2013); five studies compared therapeutic ultrasound to
placebo ultrasound (i.e. application of ultrasound with the machine
turned oM) (Ansari 2006; Durmus 2010a; Ebadi 2012; Grubisic
2006; Licciardone 2013); and one study each compared ultrasound
to spinal manipulation (Mohseni-Bandpei 2006), laser (Abdel-
Aziem 2012), or osteopathic manual treatment (Licciardone 2013).
All studies except for two, Ansari 2006; Licciardone 2013, used
stretching or strengthening exercise as an additional intervention
to ultrasound therapy, whilst Durmus 2010a also provided hot
packs to both groups.
All studies used 1 MHz continuous ultrasound at intensities
between 1 W/cm2 and 2.5 W/cm2. The duration of intervention
was diverse amongst studies. Two studies, Ansari 2006; Ebadi
2012, used Gray’s formula for calculation of the application time
(Allen 2006), whilst the other studies applied ultrasound for 5 to
10 minutes. The number of treatment sessions varied amongst
studies, from 6 sessions, Mohseni-Bandpei 2006, to 18 sessions,
Durmus 2010b; Durmus 2013. Pain intensity and back-specific
function were the most common outcomes measured in all studies.
We originally excluded the trial by Licciardone 2013 from the review
due to insuMicient data. We contacted the trial authors, and they
provided data for this version of the review.
Excluded studies
We excluded 51 studies at the full-text screening phase (see
Characteristics of excluded studies table). The most common
reasons for exclusion were that studies were not RCTs (n = 27) (Allen
2006; Borman 2003; Chipchase 2003; Cloonan 1987; Draper 1993;
Foster 1999; Gorbunov 1997; Greenough 2009; Hamm 2003; Kiralp
2009; Leistner 1989; Lopes 2009; Morrisette 2004; Nordin 1999; Onel
1993; Pensri 2005; Poitras 2005; Poitras 2008; Roman 1960; Rush
1994; Sahin 2004; Scott 2010; Si 2005; Tajali 2009; Tander 2005;
Wagner 1995; Wiesinger 1997); the ultrasound therapy was used as
part of a combination treatment (n = 17) (Bertocco 2002; Brockow
1997; Gurer 2005; Haas 2004; Hurwitz 2002; Jia 2003; Koes 1992a;
Koes 1992b; Koes 1993; Koldas 2008; Kumar 2009a; Kumar 2009b;
Kumar 2010; Li 2007; Timm 1994; Tonev 2010; Whitman 2006); and
the eMect of the ultrasound could not be separated from that of
other therapies, or participants had specific causes of low back pain
(such as spinal stenosis) (n = 7) (Acar 2012; Charlusz 2010; Fiore
2011; Goren 2010; Nwuga 1983; Santiesteban 1984; Unlu 2008).
Risk of bias in included studies
The 'Risk of bias' assessments of all included studies are provided in
the Characteristics of included studies table and summary graphs
in Figure 2 and Figure 3. Poor reporting of trial methodology in
most of the included studies resulted in unclear risk of bias across
domains. We considered only two studies to be at low risk of
bias (Ebadi 2012; Licciardone 2013), with the other eight studies
assessed as at unclear risk of bias.
 
Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 3.   'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
 
Allocation
Only four included studies clearly described the randomisation
procedure, and only two reported a concealed allocation procedure
(Ebadi 2012; Licciardone 2013). Most studies did not report
suMicient details on either the method of randomisation or of
allocation and were thus judged as at unclear risk of bias for these
items. Overall, the risk of selection bias was considered to be low in
two studies, Ebadi 2012; Licciardone 2013, and unclear in the other
eight studies.
Blinding
Participants were blinded to group allocation in five studies
through the use of placebo ultrasound (i.e. application of
ultrasound with the machine turned oM or output set to zero)
(Ansari 2006; Durmus 2010a; Ebadi 2012; Grubisic 2006; Licciardone
2013). In three studies that compared ultrasound with other
treatments (Durmus 2010b; Durmus 2013; Mohseni-Bandpei 2006),
blinding of participants was not carried out. In no study was the
care provider blinded to group allocation. Because the primary
outcome measure in all studies was self-reported, the risk of
outcome assessor bias was low in the studies in which participants
were blinded. Overall, the risk of performance bias was high in four
studies, Abdel-Aziem 2012; Durmus 2010b; Durmus 2013; Mohseni-
Bandpei 2006, and unclear in six studies. The risk of detection
bias was low in five studies (Ansari 2006; Durmus 2010a; Ebadi
2012; Grubisic 2006; Licciardone 2013), high in two studies (Durmus
2010b; Durmus 2013), and unclear in three studies.
Incomplete outcome data
In six studies (Durmus 2010a; Durmus 2010b; Durmus 2013; Ebadi
2012; Licciardone 2013; Mohseni-Bandpei 2006), dropout rates
were explained and acceptable. The rate of dropout in the study
by Ansari 2006 was 30% of the (already very small) sample
size, which renders the study as at high risk of attrition bias.
In three studies (Ansari 2006; Durmus 2010b; Durmus 2013),
participants who dropped out were excluded from the analysis.
Three studies reported that an intention-to-treat analysis had been
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performed (Durmus 2010a; Ebadi 2012; Licciardone 2013). Overall,
we considered three studies to be at high risk of attrition bias,
Abdel-Aziem 2012; Ansari 2006; Mohseni-Bandpei 2006, and three
studies as at low risk of attrition bias (Durmus 2010a; Ebadi 2012;
Licciardone 2013).
Selective reporting
Only two studies reported registration of the trial prior to
commencement (Ebadi 2012; Licciardone 2013). One of these
studies also had a published protocol available (Ebadi 2012).
Overall, we considered two studies to be at low risk of reporting bias
(Ebadi 2012; Licciardone 2013), and the other eight included studies
as at unclear risk of reporting bias.
Other potential sources of bias
None of the studies reported on compliance with the intervention.
Four studies controlled for co-interventions (Ansari 2006; Durmus
2013; Ebadi 2012; Licciardone 2013), and all of the included studies
assessed their outcomes at similar time intervals for all groups.
E=ects of interventions
See: Summary of findings 1 Therapeutic ultrasound versus
placebo; Summary of findings 2 Therapeutic ultrasound plus
exercise versus exercise alone
Therapeutic ultrasound versus placebo
The results for this comparison are presented in Summary of
findings 1. Five studies compared therapeutic ultrasound with
placebo ultrasound and reported on outcomes in the short term
(Ansari 2006; Durmus 2010a; Ebadi 2012; Grubisic 2006; Licciardone
2013). No studies reported on outcomes at intermediate- or long-
term follow-up.
Primary outcomes
Four studies provided short-term (postintervention) data on pain
intensity for this comparison (Durmus 2010a; Ebadi 2012; Grubisic
2006; Licciardone 2013). There was very low-certainty evidence
from three studies that therapeutic ultrasound results in little to no
change in pain intensity when compared to placebo in the short
term (mean diMerence (MD) −7.12, 95% confidence interval (CI)
−17.99 to 3.75; n = 121; 3 RCTs; Figure 4; Analysis 1.1) (Durmus
2010a; Ebadi 2012; Grubisic 2006). We downgraded the evidence
by three levels due to limitations in study design, imprecision,
and inconsistency. One study reported a responder analysis of
participants achieving a 30% reduction in pain intensity in the short
term (Licciardone 2013). There was moderate-certainty evidence
that therapeutic ultrasound results in little to no diMerence in the
proportion of responders in the short term compared to placebo
(risk ratio 1.08, 95% CI 0.81 to 1.44; n = 225; 1 RCT; Analysis 1.2). We
downgraded the evidence by one level due to imprecision.
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(G) Timing of outcome measures
 
Four studies provided short-term (postintervention) data on back-
specific functional status (Ansari 2006; Durmus 2010a; Ebadi 2012;
Licciardone 2013). No studies reported on intermediate- or long-
term follow-up for this outcome. There was low-certainty evidence
that therapeutic ultrasound improves back-specific functional
status when compared to placebo in the short term (standardised
mean diMerence (SMD) −0.29, 95% CI −0.51 to −0.07; converted MD
−1.07, 95% CI −1.89 to −0.26; n = 325; 4 RCTs; Figure 5; Analysis 1.3).
We downgraded the evidence by two levels due to limitations in
study design and imprecision.
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Figure 5.   Forest plot of comparison: 1 Ultrasound versus placebo ultrasound, outcome: 1.3 Back-specific functional
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(G) Timing of outcome measures
 
One study measured satisfaction with back care in the short term
and reported no diMerence between groups (Licciardone 2013).
Another study reported a participant-reported measure of overall
improvement in the short term and reported no diMerence between
groups (Grubisic 2006). Neither study reported data in a form that
permitted meta-analysis of these outcomes.
Two studies reported short-term (postintervention) data on well-
being, measured using the general health subscale of the SF-36
(Durmus 2010a; Licciardone 2013). There was moderate-certainty
evidence of little to no diMerence in well-being in the short-term
between therapeutic ultrasound and placebo (MD −2.71, 95% CI
−9.85 to 4.44; n = 267; 2 RCTs; Analysis 1.4). We downgraded the
evidence by one level due to imprecision.
None of the studies included in this comparison reported on
disability.
Only one study measured adverse events following treatment and
reported a total of 7/118 (5.9%) adverse events in the ultrasound
group and 4/107 (3.7%) events in the placebo group (Licciardone
2013). Three of these events (two in the ultrasound group, one in
the placebo group) were considered to be serious adverse events;
however, none of the reported adverse events was determined to
be related to the intervention.
The eMect sizes for all outcomes were not considered to be clinically
important.
Secondary outcomes
A 'Summary of findings' table for secondary outcomes for this
comparison is shown in Appendix 3.
Three studies provided short-term (postintervention) data on
lumbar flexion range of motion (ROM) (Ansari 2006; Ebadi 2012;
Grubisic 2006). There was very low-certainty evidence of little to no
diMerence between therapeutic ultrasound and placebo (SMD 0.18,
95% CI −0.62 to 0.98; converted MD 3.2 millimetres, 95% CI −11.1
to 17.5; n = 89; 3 RCTs; Analysis 1.5). We downgraded the evidence
for this outcome by three levels due to limitations in design, serious
imprecision, and inconsistency.
Two studies provided short-term (postintervention) data on lumbar
extension ROM (Ansari 2006; Ebadi 2012). There was very low-
certainty evidence of little to no diMerence between therapeutic
ultrasound and placebo (SMD −0.33, 95% CI −0.85 to 0.19; converted
MD −3.1 millimetres, 95% CI −7.9 to 1.8; n = 58; 2 RCTs; Analysis 1.6).
We downgraded the evidence for this outcome by three levels due
to limitations in design and serious imprecision.
None of the studies included in this comparison reported on muscle
strength as an outcome.
One study assessed muscle endurance in the short term using
the Biering-Sorensen test (Ebadi 2012). There was low-certainty
evidence of little to no diMerence between therapeutic ultrasound
and placebo (MD −11.00, 95% CI −34.94 to 12.94; n = 39; 1 RCT;
Analysis 1.7). We downgraded the evidence for this outcome by two
levels due to serious imprecision.
Therapeutic ultrasound plus exercise versus exercise alone
The results for this comparison are presented in Summary of
findings 2. Three small (total n = 109) studies compared therapeutic
ultrasound in addition to an exercise programme with an exercise
programme alone in the short term (Durmus 2010b; Durmus 2013;
Khan 2013). No studies reported on outcomes at intermediate- or
long-term follow-up.
Primary outcomes
Three studies provided short-term (postintervention) data on pain
intensity measured with the visual analogue scale (VAS). One of
the studies reported an eMect in favour of the exercise-only group
(Durmus 2010b), but only presented data graphically, which did
not allow for pooling. There was very low-certainty evidence that
ultrasound plus exercise resulted in slightly less pain than exercise
alone in the short term (MD −21.1, 95% CI −27.60 to −14.54; n = 70; 2
RCTs; Figure 6; Analysis 2.1). We downgraded the evidence by three
levels for serious limitations in study design and for imprecision.
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(G) Timing of outcome measures
 
Two studies provided short-term (postintervention) data on back-
specific functional status measured with the Oswestry Disability
Questionnaire (Durmus 2010b; Durmus 2013). There was very low-
certainty evidence of little to no diMerence between ultrasound plus
exercise and exercise alone in the short term (MD −0.41, 95% CI
−3.14 to 2.32; n = 79; 2 RCTs; Analysis 2.2). We downgraded the
evidence by three levels for limitations in study design and for
serious imprecision.
Two studies reported on short-term (postintervention) well-being
through the general health subscale of the SF-36 (Durmus 2010b;
Durmus 2013). There was very low-certainty evidence of little to no
diMerence in well-being in the short term between ultrasound plus
exercise and exercise alone (MD −2.50, 95% CI −9.53 to 4.53; n = 79;
2 RCTs; Analysis 2.3). We downgraded the evidence by three levels
for limitations in study design and for serious imprecision.
None of the studies included in this comparison reported on overall
improvement or satisfaction, disability, or adverse events.
The eMect sizes for all outcomes were not considered to be clinically
important.
Secondary outcomes
The GRADE ratings for the secondary outcomes for this comparison
are reported in Appendix 4.
Two studies also provided short-term (postintervention) data on
flexion ROM measured with the Lumbar Schober method. There
was very low-certainty evidence of little to no diMerence between
ultrasound plus exercise and exercise alone (MD 0.02, 95% CI −0.52
to 0.56; n = 79; 2 RCTs; Analysis 2.4). We downgraded the evidence by
three levels for serious limitations in study design and imprecision.
One study reported on short-term (postintervention) back flexor
and extensor muscle strength and endurance. There was very
low-certainty evidence that therapeutic ultrasound plus exercise
compared to exercise alone results in little to no diMerence in trunk
flexor strength (MD 0.65, 95% CI −0.23 to 1.53; n = 40; 1 RCT); slightly
more trunk flexor endurance (MD 4.00, 95% CI 1.09 to 6.91; n = 40; 1
RCT); and slightly more trunk extensor endurance (MD 37.35, 95% CI
33.29 to 41.41; n = 40; 1 RCT) (Analysis 2.5; Analysis 2.6; Analysis 2.7).
We downgraded the evidence by three levels for serious limitations
in study design and imprecision.
Therapeutic ultrasound versus other treatments
Five studies compared therapeutic ultrasound with other
treatments for chronic LBP (Abdel-Aziem 2012; Durmus 2010b;
Durmus 2013; Licciardone 2013; Mohseni-Bandpei 2006). All studies
reported outcomes in the short term (postintervention), and one
study reported on pain and back-specific functional status at six
months' follow-up (Mohseni-Bandpei 2006).
One study compared ultrasound to electrical stimulation and
reported on pain intensity (MD 2.50, 95% CI −3.67 to 8.67; n = 39; 1
RCT); back-specific functional status (MD 1.88, 95% CI 0.00 to 3.76;
n = 39; 1 RCT); and flexion ROM (MD 0.08, 95% CI −0.77 to 0.93; n =
39; 1 RCT) in the short term (Durmus 2010b). We do not know the
eMect of therapeutic ultrasound compared to electrical stimulation
because for all of these outcomes the certainty of the evidence was
very low (Analysis 3.1; Analysis 3.2; Analysis 3.3) (Durmus 2010b).
We downgraded the evidence for these outcomes by three levels for
serious imprecision and serious limitations in design.
One study compared ultrasound to laser and reported on pain
intensity (MD 0.40, 95% CI 0.16 to 0.64; n = 150; 1 RCT) and flexion
ROM (MD 0.48, 95% CI 0.25 to 0.71; n = 150; 1 RCT) in the short
term (Abdel-Aziem 2012). We do not know the eMect of therapeutic
ultrasound compared to laser because for both of these outcomes
the certainty of the evidence was very low (Analysis 4.1; Analysis
4.2). We downgraded the evidence for these outcomes by three
levels for imprecision and serious limitations in design.
One study compared ultrasound to phonophoresis and reported
on pain intensity (MD 0.10, 95% CI −0.68 to 0.88; n = 40; 1 RCT);
back-specific functional status (MD 1.30, 95% CI −0.47 to 3.07; n =
40; 1 RCT); well-being (MD −10.75, 95% CI −21.83 to 0.33; n = 40; 1
RCT); flexion ROM (MD 0.25, 95% CI −0.33 to 0.83; n = 40; 1 RCT);
muscle strength (MD −0.01, 95% CI −0.91 to 0.89; n = 40; 1 RCT);
and endurance (MD 2.10, 95% CI −0.70 to 4.90; n = 40; 1 RCT) in the
short term (Durmus 2013). We do not know the eMect of therapeutic
ultrasound compared to phonophoresis because for all of these
outcomes the certainty of the evidence was very low (Analysis 5.1 to
Analysis 5.7). We downgraded the evidence for these outcomes by
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three levels for serious imprecision and serious limitations in study
design.
One study compared ultrasound to spinal manipulative therapy
and reported on pain intensity, back-specific functional status,
flexion ROM, and extension ROM in the short term (Mohseni-
Bandpei 2006). There is low-certainty evidence that spinal
manipulation results in lower pain intensity than therapeutic
ultrasound in the short term (post-treatment) (MD −16.50, 95% CI
−27.55 to −5.45; n = 112; 1 RCT; Analysis 6.1). Spinal manipulation
also resulted in improved back-specific functional status (MD −7.80,
95% CI −13.19 to −2.41; n = 112; 1 RCT); flexion ROM (MD −10.00,
95% CI −14.37 to −5.63; n = 112; 1 RCT); and extension ROM (MD
−4.00, 95% CI −6.77 to −1.23; n = 112; 1 RCT) when compared with
therapeutic ultrasound. There was also low-certainty evidence of
little to no diMerence between spinal manipulation and therapeutic
ultrasound at six months' follow-up for pain intensity (MD −15.10,
95% CI −32.84 to 2.64; n = 73; 1 RCT) and back-specific functional
status (MD −5.20, 95% CI −13.05 to 2.65; n = 73; 1 RCT) (Analysis 6.5;
Analysis 6.6). We judged the evidence for these outcomes to be of
low certainty due to limitations in study design and imprecision.
One study compared ultrasound to osteopathic manual treatment
and reported on pain intensity using a responder analysis in
the short term (Licciardone 2013). There is moderate-certainty
evidence that therapeutic ultrasound results in fewer participants
reaching a 30% improvement in pain intensity compared to
osteopathic manual treatment in the short term (RR 0.75, 95% CI
0.59 to 0.95; n = 233; 1 RCT; Analysis 7.1). We judged the evidence
for this outcome to be of moderate certainty due to imprecision.
Sensitivity analysis
We planned sensitivity analyses that would exclude studies at high
risk of selection and reporting bias from the analyses. However,
only two studies had a low risk of selection and reporting bias
(Ebadi 2012; Licciardone 2013). The estimates from these studies
were consistent with the pooled estimates in the comparison
between therapeutic ultrasound and placebo (see Analysis 1.1;
Analysis 1.3).
D I S C U S S I O N
Summary of main results
Ten small RCTs (n = 1025) met the inclusion criteria for this
review (Abdel-Aziem 2012; Ansari 2006; Durmus 2010a; Durmus
2010b; Durmus 2013; Ebadi 2012; Grubisic 2006; Khan 2013;
Licciardone 2013; Mohseni-Bandpei 2006). There was very low-
certainty evidence (n = 121; 3 RCTs) that therapeutic ultrasound
results in little to no diMerence in pain intensity compared with
placebo in the short term, and moderate-certainty evidence of little
to no diMerence in the number of responders (with 30% reduction in
pain intensity) in the short term. There was low-certainty evidence
from four trials (n = 325) that therapeutic ultrasound improves
back-specific function compared with placebo in the short term,
but this diMerence was not clinically significant (MD = 1.07 points on
Roland-Morris Disability Questionnaire). There was also moderate-
certainty evidence of little to no diMerence between therapeutic
ultrasound and placebo on well-being in the short term. None of
the studies included in this comparison reported on disability. Only
one study reported on adverse events (Licciardone 2013), with no
events judged to be related to the intervention.
There was very low-certainty evidence that therapeutic ultrasound
plus exercise resulted in lower pain intensity than exercise alone
in the short term; however, this diMerence was not clinically
significant (MD 21.1 points on VAS). There was also very low-
certainty evidence of little to no diMerence in back-specific
functional status and well-being when ultrasound plus exercise
was compared to exercise alone. None of the studies included in
this comparison reported on overall improvement or satisfaction,
disability, or adverse events.
Overall completeness and applicability of evidence
Most of the available RCTs on therapeutic ultrasound for chronic
LBP are small and at unclear risk of bias. There is a lack of evidence
to support the use of therapeutic ultrasound in chronic LBP, with
studies suggesting little to no diMerence in outcomes compared to
placebo and worse outcomes compared to other active or passive
interventions. The reported data were most oSen assessed in the
short term, and the lack of intermediate- and long-term outcome
assessment restricts our ability to comment on whether any eMects
of therapeutic ultrasound manifest over a longer time period. In
most of the included studies, therapeutic ultrasound was evaluated
in combination with some form of exercise therapy, which limits
any conclusions on the eMectiveness of ultrasound as a uni-modal
treatment. Not all recommended outcome measures for studies on
LBP (such as pain and back-specific function) were measured by
all studies (Furlan 2015). The reporting of ultrasound application
parameters and dose was inconsistent in the included studies,
which meant that no conclusions on the most eMective dose could
be made. No study reported on calibration of the ultrasound device
prior to or between treatment sessions.
Quality of the evidence
The small sample sizes in the included studies led to the
downgrading of the evidence (i.e. imprecision) for most of the
treatment comparisons. As a result, there was mostly low- to very
low-certainty evidence for the outcomes in the comparisons of
interest to this review. Most studies were aMected by poor reporting;
were not registered prior to commencement; or did not publish
protocols, which made assessment of the risk of bias diMicult.
Whilst most studies blinded the participant or outcome assessor, no
study was able to appropriately blind the caregiver (therapist). In
addition, there was a lack of information from most studies about
compliance with therapeutic ultrasound or adverse events.
Potential biases in the review process
We made all attempts to reduce the bias involved with the review
process. Where review authors were also authors of an included
study, external reviewers were consulted to apply the eligibility
criteria, extract the data, and perform the 'Risk of bias' assessment.
In the case of missing data, we made attempts to obtain the
information from the authors of included studies.
Agreements and disagreements with other studies or
reviews
This review is in agreement with previous systematic reviews
on the eMects of ultrasound therapy, which identify a lack of
high-quality evidence and limited support for ultrasound as an
eMective intervention for chronic musculoskeletal disorders (Chou
2017; Qaseem 2017). The latest guidelines on the management of
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chronic LBP recommend that clinicians do not oMer ultrasound for
managing low back pain with or without sciatica (NICE 2016).
A U T H O R S '   C O N C L U S I O N S
Implications for practice
There is a lack of large, high-quality studies that have investigated
the eMect of therapeutic ultrasound for chronic low back pain (LBP).
Despite various outcome measures being used by the studies in
this review to highlight diMerent facets of chronic LBP, the evidence
to support the use of therapeutic ultrasound in practice is limited.
EMect sizes are small, and any improvements do not appear to be
clinically meaningful. There is very limited information available on
adverse events following therapeutic ultrasound. Other active and
passive interventions are likely to result in better outcomes than
therapeutic ultrasound for individuals with chronic LBP.
Implications for research
Whilst further research is likely to have an important impact
on our confidence in the estimates of eMect of therapeutic
ultrasound, there is little to suggest that this research will uncover
a benefit from therapeutic ultrasound that is clinically meaningful
for individuals with chronic LBP. In order to identify whether
therapeutic ultrasound has any clinically important eMect on
chronic LBP and to investigate the implications of varying dose,
intensity, and application type, randomised controlled trials with
low risk of bias and adequate sample size would be required. Future
trials would need to include long-term outcome measurements,
record any potential adverse eMects, and consider the cost-
eMectiveness of ultrasound treatment compared with usual care in
order to improve the evidence base. However, based on the findings
of this systematic review, further research in the field of chronic LBP
in other areas would likely be of greater value.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods RCT conducted in outpatient physiotherapy clinic (secondary care setting)
Participants 150 patients with mechanical low back pain collected from the public and private hospitals, and stu-
dent of College of Applied Medical Sciences in Taif, participated in this study. Participant were random-
ly assigned to 2 equal groups.
Exclusion criteria: neurological disorders (as lumbar disc prolapse, polyneuropathy, sciatica), develop-
mental, congenital or neuromuscular scoliosis and previous back or abdominal surgeries, also obese
patients have been excluded
Interventions A) Laser treatment group: infrared laser therapy (904 N·m) 3 times per week at the level of low back par-
avertebral muscles at a power of 1 to 2 J/cm2; Low-Intensity Laser Therapy (LILT). In combination with
traditional exercise therapy.
(B) Ultrasound treatment group: ultrasound therapy 3 times per week on low back paravertebral mus-
cles, 1.5 W/cm2 at a frequency of 1 MHz, in combination with traditional exercise therapy.
Outcomes VAS and ROM pre-treatment, after 4 weeks and after 8 weeks. Both groups showed improvement in
both outcomes after 4 and 8 weeks.
Notes The analysis and the reporting of the results are vague, so some results are not reported in the table
due to ambiguity.
Risk of bias
Bias Authors' judgement Support for judgement
Abdel-Aziem 2012 
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Random sequence genera-
tion (selection bias)
Unclear risk Reports "randomly distributed"; method of sequence generation not reported
Allocation concealment
(selection bias)










High risk Not reported in text, unlikely to be blinded
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk ROM is not reported for different movements (flexion, extension, lateral flex-




High risk ROM is not reported for different movements (flexion, extension, lateral flex-
ion) and is reported by only 1 score.
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Similar groups Unclear risk No comparison is reported; only raw data.
Co-interventions High risk Manipulation was delivered to all participants, which can be considered to be
a co-intervention.
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures





Methods RCT conducted in outpatient physiotherapy clinic (secondary care setting)
Participants 15 participants were randomised, who were aged 18 to 65 years with non-radiating, non-specific low
back pain lasting for more than 3 months. Exclusion criteria were: abnormal neurological status; con-
comitant severe disease; psychiatric illness; current psychotherapy; pathological lumbosacral X-rays
(except for minor degenerative changes); rheumatic inflammatory disease; planned hospitalisation;
addiction to any kind of substance; and any contraindication to ultrasound therapy.
Interventions Intervention (I) group (n = 5) received 1 MHz continuous ultrasound, at 1.5 W/cm2 for 10 sessions, 3 days
per week. Duration of ultrasound application was calculated according to the formula: total treatment
time = planned average local exposure time x (tissue area/effective radiation area of applicator).
Ansari 2006 
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Control (C) group (n = 5) received placebo ultrasound for 10 sessions, 3 days per week.
Outcomes Mean (SD) pre- and post-treatment scores on Functional Rating Index were: (I) 56.5 (20.35), 34.5 (13.5);
and (C) 46.95 (14.38), 39.9 (16.5). Mean (SD) pre- and post-treatment degrees of flexion range of motion
were: (I) 117.4 (2.5), 128.6 (14.3); and (C) 103.4 (13.39), 109.2 (10.6). Mean (SD) pre- and post-treatment
degrees of extension range of motion were: (I) 23.8 (4.15), 30 (6.4); and (C) 27.2 (3.03), 29 (4.2).
No between-group difference was seen for H-reflex parameters (electroneurophysiological evaluation)
or in lumbar spine lateral flexion (leS and right) range of motion.
Notes No conflict of interest declared with regard to commercial funding.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method for determining randomisation sequence not reported in text.
Allocation concealment
(selection bias)










High risk Care providers not blinded.
Blinding of outcome as-
sessment (detection bias)
All outcomes









High risk Participants who dropped out were excluded from analysis.
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Similar groups High risk Large differences in gender, age, BMI between groups
Co-interventions Low risk Participants advised not to commence new treatments.
Compliance High risk High proportion of dropouts due to noncompliance.
Timing of outcome mea-
sures
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Study characteristics
Methods RCT conducted in unknown setting (not reported)
Participants 42 patients (29 females and 13 males) with chronic LBP lasting for at least 3 months were included in
the study. Patients were excluded from the study for the following reasons: evidence of acute radicu-
lopathy; the presence of an inflammatory disease, neoplastic disease, spondylolysis, spondylolisthesis,
or sacroiliitis; lumbar disc herniation requiring surgical treatment; vertebral fractures; pregnancy.
Interventions Intervention (I) group (n = 21) participants received hot packs (15 minutes), ultrasound, and exercise. In
this group, 1 MHz continuous ultrasound was applied to the lumbar paravertebral region at an intensity
of 1 W/cm2 for 10 minutes using a probe with an effective radiating area of 5 cm2.
Control (C) group (n = 21) participants received hot packs (15 minutes), placebo ultrasound, and exer-
cise. Placebo ultrasound was applied to the same region for the same duration, with the same ultra-
sound device. No current was applied, but the device and the indicator lights were kept in the 'on' posi-
tion.
Both groups performed range of motion, stretching (hamstring, pelvic, and abdominal muscles), and
strengthening (cervical, thoracic, and lumbar region muscles) exercises for 15 minutes. Participants
were treated 5 days a week for 3 weeks.
Outcomes Median (range) scores on the modified Oswestry Low Back Pain Disability Questionnaire pre- and post-
treatment were: (I) 38 (26 to 76), 12 (1 to 32); and (C) 44 (22 to 50), 17 (6 to 23). Median (range) scores on
the VAS at rest pre- and post-treatment were: (I) 6 (3 to 10), 2 (1 to 5); and (C) 6 (3 to 9), 4 (1 to 9).
Significantly greater improvement was observed in (I) compared to (C) in Pain Disability Index scores, 6-
minute walk test, emotional and physical role functioning (SF-36), functional performance, and depres-
sion.
Notes Attempts made to contact authors for further data (as all data were reported as median (range)) were
met with no response.
No conflict of interest declared with regard to commercial funding.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method for determining randomisation sequence not reported in text.
Allocation concealment
(selection bias)










High risk Care providers not blinded.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Primary outcome measures are self-reported, participants blind to group allo-
cation.
Durmus 2010a 
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Low risk No dropouts reported, presumed complete outcome data were available.
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Similar groups Low risk Groups were well matched at baseline.
Co-interventions Unclear risk Not reported in text
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures





Methods RCT conducted in outpatient department (secondary care setting)
Participants 68 female patients who had been experiencing low back pain for at least 3 months were included. Ex-
clusion criteria were: acute radicular signs or symptoms, radiographic evidence of inflammatory dis-
ease affecting the spine, tumour, spondylolysis, spondylolisthesis, or sacroiliitis, serious medical con-
ditions for which exercise would be contraindicated, neuromuscular or dermatologic disease that in-
volves the lumbar and abdominal area, were currently in an exercise programme, implanted cardiac
pacemaker or defibrillator, contracture, previous trauma, history of spinal surgery, pregnancy, pres-
ence of severe structural deformity.
Interventions Group 1 (n = 20) was given an electrical stimulation programme and back and abdominal exercises (45
min).
Group 2 (n = 19) was given a 10-minute ultrasound treatment (1 MHz frequency and 1 W/cm2 intensity
and a transducer head with an area of 5 cm, an effective radiating area of 4 cm, and a BNR of 1:5) and
back and abdominal exercises (45 min).
Group 3 (n = 20) acted as the control group and was given only back and abdominal exercises (45 min).
All of the programmes were 45 minutes per session, performed 3 days a week, for a duration of 6
weeks. Participants were evaluated pre-treatment and in the third and sixth weeks of the therapy.
Outcomes 59 participants completed the study. The post-treatment (6-week) between-group comparison did not
show a significant difference in Pain Disability Index, Oswestry Disability Questionnaire, range of mo-
tion (modified lumbar Schober, lumbar Schober, fingertip to floor distance), 6-minute walk distance, or
muscle strength between the 3 groups.
There was a significantly greater improvement in physical function, energy, and social function scores
of the SF-36, VAS, and muscle endurance in groups 1 and 2 compared to group 3. There was no signifi-
cant difference between groups 1 and 2 in these outcomes.
Notes No conflict of interest declared with regard to commercial funding.
Durmus 2010b 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method for determining randomisation sequence not reported in text.
Allocation concealment
(selection bias)










High risk Care providers not blinded.
Blinding of outcome as-
sessment (detection bias)
All outcomes








High risk Dropouts excluded from analysis.
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Similar groups Low risk Groups were well matched at baseline.
Co-interventions Unclear risk Not reported in text
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures





Methods RCT conducted in outpatient department (secondary care setting)
Participants 64 female patients who had been experiencing low back pain for at least 3 months were included. Ex-
clusion criteria were: acute radicular signs or symptoms, radiographic evidence of inflammatory dis-
ease affecting the spine, tumour, spondylolysis, spondylolisthesis, or sacroiliitis, serious medical con-
ditions for which exercise would be contraindicated, neuromuscular or dermatologic disease that in-
volves the lumbar and abdominal area, were currently in an exercise programme, implanted cardiac
Durmus 2013 
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pacemaker or defibrillator, contracture, previous trauma, history of spinal surgery, pregnancy, pres-
ence of severe structural deformity.
Interventions Group 1 (n = 20) was given a group exercise programme for 60 min, 3 times per week for 6 weeks.
Group 2 (n = 20) was given a 10-minute ultrasound treatment (1 MHz frequency and 1.5 W/cm2 intensi-
ty and a transducer head with an area of 5 cm, an effective radiating area of 4 cm, and a BNR of 1:5), 3
times per week for 6 weeks, and the same exercise programme as group 1.
Group 3 (n = 20) was given phonophoresis therapy by applying 2 to 3 mm of capsaicin gel (10% cap-
sicum oleoresin in 0.22% solution) then a 10-minute ultrasound treatment (as per group 2), 3 times per
week for 6 weeks, as well as the same exercise programme as group 1.
Participants were evaluated pre-treatment and after 6 weeks (post-treatment).
Outcomes 60 participants completed the study. The post-treatment (6-week) between-group comparison showed
a significant difference in VAS pain, walking performance (6-minute walk test), and extensor muscle
strength in favour of groups 2 and 3 compared to group 1. There was no significant difference between
groups 2 and 3.
There was a significantly greater improvement in pain, physical function, and energy subscales of the
SF-36 in group 3 compared to groups 1 and 2.
Notes No conflict of interest declared with regard to commercial funding.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method for determining randomisation sequence not reported in text.
Allocation concealment
(selection bias)










High risk Care providers not blinded.
Blinding of outcome as-
sessment (detection bias)
All outcomes








High risk Dropouts excluded from analysis.
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Durmus 2013  (Continued)
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Similar groups Low risk Groups were well matched at baseline.
Co-interventions Low risk Medication controlled during intervention period.
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures





Methods RCT conducted in outpatient department (secondary care setting)
Participants 50 patients aged between 18 and 60 years with non-specific chronic low back pain were randomised.
Exclusion criteria were: nerve root symptoms; systemic disease and specific conditions such as neo-
plasm, fractures, spondylolisthesis, spondylolysis, spinal stenosis, ankylosing spondylitis; previous low
back surgery; taking medication for specific psychological problems; and pregnancy. Participants were
recruited from 3 university hospitals in Tehran, Iran.
Interventions The intervention (I) group (n = 24) received continuous ultrasound plus semi-supervised exercise. Con-
tinuous ultrasound with a frequency of 1 MHz and an intensity of 1.5 W/cm2 was applied to the painful
paravertebral low back region. The duration of US was estimated for each participant using the formu-
la: total treatment time = planned average local exposure time x (tissue area/effective radiation area of
applicator).
The (C) control group (n = 24) received placebo ultrasound plus semi-supervised exercise. Placebo ul-
trasound involved the machine being turned on, with lights visible to the participant, but no current
being applied.
All participants in both groups received 10 sessions of treatment, 3 times a week, every other day.
Outcomes 48 participants completed treatment sessions. Mean (SD) pre- and post-treatment scores for VAS were:
(I) 46.6 (17.7), 26.6 (13.8); and (C) 49 (16), 30.7 (13.1). Mean (SD) pre- and post-treatment scores for Func-
tional Rating Index were: (I) 40.8 (14.6), 23.4 (6.9); and (C) 43.9 (16.9), 31.1 (13.4). Changes in lumbar
range of motion, muscle endurance, and median frequency slope of all measured paravertebral mus-
cles were not significantly different between groups.
Notes No conflict of interest declared with regard to commercial funding.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation schedule
Allocation concealment
(selection bias)





Low risk Participants blinded to group allocation.
Ebadi 2012 
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High risk Care providers not blinded.
Blinding of outcome as-
sessment (detection bias)
All outcomes









Low risk All randomised participants included in analysis.
Selective reporting (re-
porting bias)
Low risk Trial was pre-registered and published protocol was available. All outcomes
reported.
Similar groups Low risk Groups were well matched at baseline.
Co-interventions Low risk Participants advised not to commence new treatments.
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures





Methods RCT conducted in specialist clinic (secondary care setting)
Participants 31 participants, aged 38 to 77 years, with low back pain lasting more than 3 months and intensity of
pain on VAS at least 50 mm, were randomised. Exclusion criterion was non-mechanical low back pain.
Interventions Intervention (I) group (n = 15) received ultrasound to the paravertebral muscles at an intensity of 1.2 W/
cm2 for 5 minutes plus kinesitherapy for 10 sessions over 2 weeks.
Control (C) group (n = 16) received placebo ultrasound plus kinesitherapy for 10 sessions over 2 weeks.
Outcomes Mean (SD) pre- and post-treatment scores on VAS were: (I) 82.7 (14.0), 79.8 (12.2); and (C) 81.7 (12.1),
78.9 (12.1). Mean (SD) pre- and post-treatment range of motion (cm) measures were: (I) 5.7 (0.8), 5.8
(0.9); and (C) 5.4 (0.9), 5.6 (1.0).
There was no significant difference between groups regarding patient and physician global perceived
efficacy.
Notes Article originally published in Croatian. No conflict of interest declared with regard to commercial fund-
ing.
Risk of bias
Bias Authors' judgement Support for judgement
Grubisic 2006 
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Random sequence genera-
tion (selection bias)
Unclear risk Method for determining randomisation sequence not reported in text.
Allocation concealment
(selection bias)










High risk Care providers not blinded.
Blinding of outcome as-
sessment (detection bias)
All outcomes









Unclear risk Not reported in text
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Similar groups Low risk Groups were well matched at baseline.
Co-interventions Unclear risk Not reported in text
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures





Methods RCT conducted in outpatient physiotherapy clinic (secondary care setting)
Participants 30 patients from Raj Nursing Home (age 25 to 65 years) who were diagnosed with low back pain, with
onset > 1 to 3 months (chronic)
Interventions Participants were randomly assigned to either group A receiving US and exercise combined or group B
receiving exercise alone.
Participants in both groups received 10 sessions of treatment, each about 20 minutes, over 4 weeks.
In group A, US dose was 1 W/cm2 with frequency of 1 MHz in continuous mode for 8 minutes over the
Khan 2013 
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paravertebral low back region. Group B received placebo US. Both groups received stretching and
strengthening exercises.
Outcomes VAS: both groups had significant reduction.
McGill Pain Questionnaire (PRI/PPI): both groups had significant reduction.
Notes No statistical analysis was performed to address the difference between groups regarding the amount
of change.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method for determining randomisation sequence not reported in text.
Allocation concealment
(selection bias)










High risk Not reported in text, unlikely to be blinded
Blinding of outcome as-
sessment (detection bias)
All outcomes








Unclear risk Unclear if all cases were analysed or what method of analysis was used
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Similar groups Unclear risk Not reported in text
Co-interventions Unclear risk Not reported in text
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures
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Study characteristics
Methods RCT with 2 x 2 factorial design
Participants 455 patients aged 21 to 69 years with low back pain for at least 3 months recruited through newspa-
per advertisements, community agencies, and medical clinics. Exclusion criteria included pregnancy,
red-flag conditions (cancer, spinal osteomyelitis, spinal fracture, herniated disc, ankylosing spondyli-
tis, or cauda equina syndrome); low back surgery in the past year; workers' compensation benefits in
the past 3 months; ongoing litigation involving back problems; angina or congestive heart failure symp-
toms with minimal activity, history of a stroke, or transient ischaemic attack in the past year; implant-
ed biomedical devices (such as cardiac pacemakers or artificial joints); active bleeding or infection in
the lower back, or other conditions impeding protocol implementation; use of corticosteroids in the
past month; or use of manual treatment (osteopathic or manual therapies delivered by chiropractors
or physical therapists) or therapeutic ultrasound in the past 3 months or more than 3 times in the past
year. Candidates whose screening was successful by telephone received a clinical screening to exclude
those with a high probability of lumbar radiculopathy, a relative contraindication to osteopathic manu-
al therapy (OMT).
Interventions Participants were allocated to 4 groups: OMT plus ultrasound, OMT plus placebo ultrasound, placebo
OMT plus ultrasound, or placebo OMT plus placebo ultrasound.
Treatments were scheduled at weeks 0, 1, 2, 4, 6, and 8 using 15 different physicians. Participants could
self-initiate low back pain co-interventions, such as non-prescription drugs, complementary and alter-
native medicine therapies, or usual care.
Outcomes The current level of low back pain was measured before each treatment and at week 12 using a 100-
millimetre VAS. Secondary outcomes were measured at baseline and at weeks 4, 8, and 12 using the
Roland-Morris Disability Questionnaire, Medical Outcomes Study Short Form-36 Health Survey gener-
al health scale, number of lost workdays in the past 4 weeks because of low back pain, and satisfaction
with back care on a 5-point Likert scale.
Notes Data are not published separately for the 4 randomised groups. We contacted the authors, who provid-
ed stratified outcome data (unpublished).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Assignments were then conveyed directly to the physicians using numbered,











High risk Providers unable to be blinded.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Self-reported measure, participants blinded to intervention
Licciardone 2013 
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Low risk Intention-to-treat analysis presented.
Selective reporting (re-
porting bias)
Low risk Trial was pre-registered, and all relevant outcomes were presented. No pub-
lished protocol available.
Similar groups Low risk Baseline measures similar across groups (Table 1).
Co-interventions Low risk Measured co-treatments reported by participants
Compliance High risk Relatively high contraindication and adverse event rate (4% serious adverse
events)
Timing of outcome mea-
sures





Methods RCT conducted in outpatient physiotherapy department (secondary care setting)
Participants 120 individuals aged between 18 and 55 years with pain greater than 3 months were recruited and ran-
domised into 2 groups of 60 participants. Individuals were excluded if they had an underlying disease
such as malignancy, obvious disc herniation, osteoporosis, viscerogenic causes, infection or systemic
disease of the musculoskeletal system; previous spinal manipulation therapy or ultrasound treatment;
neurologic or sciatic nerve root compression, radicular pain, sensory disturbances, loss of strength and
reflexes; previous back surgery; evidence of previous vertebral fractures or major structural abnormali-
ty; tumour of the spine; pregnancy; devices such as heart
pacemakers that could be affected by electrical stimulation; or registered disabled or receiving any
type of benefits because of their LBP.
Interventions The manipulation/exercise group (n = 56) received spinal manipulation with an exercise programme.
On average, each participant was seen for 4 sessions (range 2 to 7 sessions), once or twice per week.
The ultrasound/exercise group (n = 56) received ultrasound with the same exercise programme. Con-
tinuous ultrasound with a frequency of 1 MHz and intensity between 1.5 and 2.5 W/cm2 for a period of
5 to 10 minutes was applied. On average, each participant was seen for 6 sessions (range 3 to 11 ses-
sions), once or twice per week.
Outcomes 112 participants completed the study. Post-treatment, between-group analysis showed that partici-
pants in the manipulation/exercise group demonstrated a significantly greater reduction in pain in-
tensity and functional disability, as well as improved lumbar flexion and extension, than the ultra-
sound/exercise group. No significant difference was found between groups for measures of median fre-
quency for either the multifidus or the iliocostalis lumborum muscle. A significant difference was found
in the median frequency slope between groups for multifidus alone in favour of the manipulation/exer-
cise group. These differences persisted at the 6-month follow-up.
Notes No conflict of interest declared with regard to commercial funding.
Risk of bias
Mohseni-Bandpei 2006 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Block style randomization scheme" with reference
Allocation concealment
(selection bias)










High risk Care providers not blinded to group.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Outcome assessor blinded to group allocation, however primary outcome was








High risk Dropouts excluded from analysis.
Selective reporting (re-
porting bias)
Unclear risk No trial pre-registration or published protocol was available.
Similar groups Low risk Groups were well matched at baseline.
Co-interventions Unclear risk Not reported in text
Compliance Unclear risk Not reported in text
Timing of outcome mea-
sures
Low risk Similar timing of outcome assessment (post-treatment) for both groups
Mohseni-Bandpei 2006  (Continued)
BMI: body mass index
BNR: beam non-uniformity ratio
LBP: low back pain
RCT: randomised controlled trial
SD: standard deviation
US: ultrasound
VAS: visual analogue scale
ROM: Range of Motion
SF-36:Short Form Health Survey questionnaire
PRI/PPI: Pain Rating Index/present pain intensity
 
Characteristics of excluded studies [ordered by study ID]
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Study Reason for exclusion
Acar 2012 Not participants with low back pain
Allen 2006 Not a randomised controlled trial
Bertocco 2002 Ultrasound as part of treatment package
Borman 2003 Not a randomised controlled trial
Brockow 1997 All groups had ultrasound – no control intervention
Charlusz 2010 Participants with acute low back pain
Chipchase 2003 Not a randomised controlled trial
Cloonan 1987 Not a randomised controlled trial
Draper 1993 Not a randomised controlled trial
Fiore 2011 Participants with acute low back pain
Foster 1999 Not a randomised controlled trial
Gorbunov 1997 Not a randomised controlled trial
Goren 2010 Participants with lumbar spinal stenosis
Greenough 2009 Not a randomised controlled trial
Gurer 2005 Ultrasound as part of treatment package
Haas 2004 Ultrasound as part of treatment package
Hamm 2003 Not a randomised controlled trial
Hurwitz 2002 Ultrasound as part of treatment package
Jia 2003 Ultrasound as part of treatment package
Kiralp 2009 Not a randomised controlled trial
Koes 1992a Ultrasound as part of treatment package
Koes 1992b Ultrasound as part of treatment package
Koes 1993 Ultrasound as part of treatment package
Koldas 2008 Ultrasound as part of treatment package
Kumar 2009a Ultrasound as part of treatment package
Kumar 2009b Ultrasound as part of treatment package
Kumar 2010 Ultrasound as part of treatment package
Leistner 1989 Not a randomised controlled trial
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Study Reason for exclusion
Li 2007 Ultrasound as part of treatment package
Lopes 2009 Not a randomised controlled trial
Morrisette 2004 Not a randomised controlled trial
Nordin 1999 Not a randomised controlled trial
Nwuga 1983 Participants with acute low back pain
Onel 1993 Not a randomised controlled trial
Pensri 2005 Not a randomised controlled trial
Poitras 2005 Not a randomised controlled trial
Poitras 2008 Not a randomised controlled trial
Roman 1960 Not a randomised controlled trial
Rush 1994 Not a randomised controlled trial
Sahin 2004 Not a randomised controlled trial
Santiesteban 1984 Participants with acute low back pain
Scott 2010 Not a randomised controlled trial
Si 2005 Not a randomised controlled trial
Tajali 2009 Not a randomised controlled trial
Tander 2005 Not a randomised controlled trial
Timm 1994 Ultrasound as part of treatment package
Tonev 2010 Ultrasound as part of treatment package
Unlu 2008 Participants with acute low back pain
Wagner 1995 Not a randomised controlled trial
Whitman 2006 Participants with lumber spinal stenosis; ultrasound as part of treatment package
Wiesinger 1997 Not a randomised controlled trial
 
Characteristics of studies awaiting classification [ordered by study ID]
 
Methods Randomised controlled trial
Participants 50 participants with low back pain for greater than 90 days
Ojoawo 2019 
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Interventions Intervention (n = 25): pulsed ultrasound, stabilisation exercise, and Lofnac gel
Control (n = 25): kneading massage, stabilisation exercise, and Lofnac gel





Methods Randomised controlled trial
Participants 100 women, 18 to 40 years of age, with chronic non-specific low back pain (VAS between 4 and 7)
for longer than 4 months
Interventions Intervention (n = 28): pulsed ultrasound
Intervention (n = 30): continuous ultrasound
Control (n = 29): pulsed laser
Control (n = 24): no treatment





Methods Randomised controlled trial
Participants 45 participants with chronic non-specific low back pain, aged 30 to 40 years
Interventions Intervention (n = 15): continuous ultrasound plus exercise
Control (n = 15): laser photobiomodulation therapy plus exercise
Control (n = 15): exercise
Outcomes Pain intensity (VAS); back-specific functional status (Modified Oswestry Low Back Pain Disability





Methods Randomised controlled trial
Participants 69 participants with chronic low back pain
Interventions Intervention (n = 23): ultrasound plus hot pack and TENS
Control (n = 23): hot pack and TENS
Yurdakul 2019 
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Control (n = 23): no intervention
Outcomes Pain intensity (numerical rating scale); back-specific functional status (Oswestry Low Back Pain Dis-
ability Questionnaire); well-being (SF-36)
Notes All participants were prescribed paracetamol 500 mg 3 times a day during the study period and
were advised not to exercise until the end of the treatment.
Yurdakul 2019  (Continued)
TENS: transcutaneous electrical nerve stimulation
SF-36: 36-item Short Form Health Survey
VAS: visual analogue scale
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name Efficacy of ultrasound versus short wave diathermy in the treatment of a slipped disc of the lower
back
Methods Randomised controlled trial
Participants 93 participants aged 20 to 60 years old, with low back pain for greater than 3 months
Interventions Group 1: ultrasound plus TENS, hot pack, exercise
Group 2: short-wave diathermy plus TENS, hot pack, exercise
Group 3: TENS, hot pack, exercise
Outcomes Pain intensity, disability, health-related quality of life
Starting date 14 September 2018
Contact information Selin Ozen; selinhassan@hotmail.com
Notes Estimated completion date 30 June 2020
NCT03835182 
TENS: transcutaneous electrical nerve stimulation
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Ultrasound versus placebo ultrasound





Statistical method Effect size
1.1 Pain (VAS) short-term 3 121 Mean Difference (IV, Random, 95% CI) -7.12 [-17.99, 3.75]
1.2 Pain (VAS responder analysis 30% re-
duction) short-term
1 225 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.81, 1.44]
1.3 Back-specific functional status (various
scales) short-term
4 325 Std. Mean Difference (IV, Random,
95% CI)
-0.29 [-0.51, -0.07]
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Statistical method Effect size
1.4 Well-being (general health subscale of
SF-36) short-term
2 267 Mean Difference (IV, Random, 95% CI) -2.71 [-9.85, 4.44]
1.5 Flexion ROM (various scales) short-term 3 89 Std. Mean Difference (IV, Random,
95% CI)
0.18 [-0.62, 0.98]
1.6 Extension ROM (various scales) short-
term
2 58 Std. Mean Difference (IV, Random,
95% CI)
-0.33 [-0.85, 0.19]
1.7 Trunk extensor muscle endurance
(Biering-Sorensen test) short-term










Heterogeneity: Tau² = 70.59; Chi² = 8.73, df = 2 (P = 0.01); I² = 77%
Test for overall effect: Z = 1.28 (P = 0.20)



































IV, Random, 95% CI [mm]
-20.00 [-31.19 , -8.81]
-4.10 [-11.71 , 3.51]
0.90 [-7.66 , 9.46]
-7.12 [-17.99 , 3.75]
Mean Difference
IV, Random, 95% CI [mm]
-100 -50 0 50 100
Favours [ultrasound] Favours [placebo]
 
 
Analysis 1.2.   Comparison 1: Ultrasound versus placebo ultrasound,






Test for overall effect: Z = 0.53 (P = 0.60)



















M-H, Random, 95% CI
1.08 [0.81 , 1.44]
1.08 [0.81 , 1.44]
Risk Ratio
M-H, Random, 95% CI
0.5 0.7 1 1.5 2
Favours [placebo] Favours [ultrasound]
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Analysis 1.3.   Comparison 1: Ultrasound versus placebo ultrasound,







Heterogeneity: Tau² = 0.00; Chi² = 2.35, df = 3 (P = 0.50); I² = 0%
Test for overall effect: Z = 2.57 (P = 0.01)










































IV, Random, 95% CI
-0.71 [-1.30 , -0.13]
-0.26 [-1.51 , 0.98]
-0.22 [-0.48 , 0.04]
-0.20 [-0.81 , 0.40]
-0.29 [-0.51 , -0.07]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours [ultrasound] Favours [placebo]
 
 
Analysis 1.4.   Comparison 1: Ultrasound versus placebo ultrasound,





Heterogeneity: Tau² = 9.40; Chi² = 1.40, df = 1 (P = 0.24); I² = 29%
Test for overall effect: Z = 0.74 (P = 0.46)




























IV, Random, 95% CI
3.09 [-8.91 , 15.09]
-5.00 [-10.93 , 0.93]
-2.71 [-9.85 , 4.44]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [placebo] Favours [ultrasound]
 
 
Analysis 1.5.   Comparison 1: Ultrasound versus placebo






Heterogeneity: Tau² = 0.31; Chi² = 5.63, df = 2 (P = 0.06); I² = 64%
Test for overall effect: Z = 0.43 (P = 0.67)



































IV, Random, 95% CI
1.39 [-0.07 , 2.86]
-0.40 [-0.97 , 0.17]
0.20 [-0.50 , 0.91]
0.18 [-0.62 , 0.98]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours [placebo] Favours [ultrasound]
Footnotes
(1) converted to mm
 
 
Therapeutic ultrasound for chronic low back pain (Review)









Cochrane Database of Systematic Reviews
Analysis 1.6.   Comparison 1: Ultrasound versus placebo





Heterogeneity: Tau² = 0.00; Chi² = 0.75, df = 1 (P = 0.39); I² = 0%
Test for overall effect: Z = 1.25 (P = 0.21)




























IV, Random, 95% CI
0.17 [-1.08 , 1.41]
-0.44 [-1.01 , 0.13]
-0.33 [-0.85 , 0.19]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours [placebo] Favours [ultrasound]
 
 
Analysis 1.7.   Comparison 1: Ultrasound versus placebo ultrasound, Outcome





Test for overall effect: Z = 0.90 (P = 0.37)





















IV, Random, 95% CI [seconds]
-11.00 [-34.94 , 12.94]
-11.00 [-34.94 , 12.94]
Mean Difference
IV, Random, 95% CI [seconds]
-100 -50 0 50 100
Favours [placebo] Favours [ultrasound]
 
 
Comparison 2.   Ultrasound plus exercise versus exercise alone





Statistical method Effect size
2.1 Pain (VAS) short-term 2 70 Mean Difference (IV, Random, 95% CI) -21.07 [-27.60,
-14.54]
2.2 Back-specific functional status (Os-
westry) short-term
2 79 Mean Difference (IV, Random, 95% CI) -0.41 [-3.14, 2.32]
2.3 Well-being (general health subscale
of SF-36) short-term
2 79 Mean Difference (IV, Random, 95% CI) -2.50 [-9.53, 4.53]
2.4 Flexion ROM (Schober test) short-
term
2 79 Mean Difference (IV, Random, 95% CI) 0.02 [-0.52, 0.56]
2.5 Trunk flexor strength short-term 1 40 Mean Difference (IV, Random, 95% CI) 0.65 [-0.23, 1.53]
2.6 Trunk flexor endurance short-term 1 40 Mean Difference (IV, Random, 95% CI) 4.00 [1.09, 6.91]
2.7 Trunk extensor endurance short-
term
1 40 Mean Difference (IV, Random, 95% CI) 37.35 [33.29, 41.41]
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Heterogeneity: Tau² = 7.97; Chi² = 1.53, df = 1 (P = 0.22); I² = 34%
Test for overall effect: Z = 6.32 (P < 0.00001)




























IV, Random, 95% CI
-17.00 [-25.70 , -8.30]
-23.80 [-30.18 , -17.42]
-21.07 [-27.60 , -14.54]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [ultrasound + ex] Favours [exercise]
 
 
Analysis 2.2.   Comparison 2: Ultrasound plus exercise versus exercise





Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.99); I² = 0%
Test for overall effect: Z = 0.30 (P = 0.77)




























IV, Random, 95% CI
-0.42 [-4.22 , 3.38]
-0.40 [-4.31 , 3.51]
-0.41 [-3.14 , 2.32]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours [ultrasound + ex] Favours [exercise]
 
 
Analysis 2.3.   Comparison 2: Ultrasound plus exercise versus exercise





Heterogeneity: Tau² = 0.00; Chi² = 0.95, df = 1 (P = 0.33); I² = 0%
Test for overall effect: Z = 0.70 (P = 0.49)




























IV, Random, 95% CI
1.27 [-9.07 , 11.61]
-5.75 [-15.34 , 3.84]
-2.50 [-9.53 , 4.53]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [exercise] Favours [ultrasound + ex]
 
 
Analysis 2.4.   Comparison 2: Ultrasound plus exercise versus





Heterogeneity: Tau² = 0.00; Chi² = 0.05, df = 1 (P = 0.83); I² = 0%
Test for overall effect: Z = 0.06 (P = 0.95)




























IV, Random, 95% CI
0.07 [-0.66 , 0.80]
-0.05 [-0.86 , 0.76]
0.02 [-0.52 , 0.56]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours [exercise] Favours [ultrasound +ex]
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Analysis 2.5.   Comparison 2: Ultrasound plus exercise versus





Test for overall effect: Z = 1.44 (P = 0.15)





















IV, Random, 95% CI
0.65 [-0.23 , 1.53]
0.65 [-0.23 , 1.53]
Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours [exercise] Favours [ultrasound + ex]
 
 
Analysis 2.6.   Comparison 2: Ultrasound plus exercise versus





Test for overall effect: Z = 2.69 (P = 0.007)





















IV, Random, 95% CI
4.00 [1.09 , 6.91]
4.00 [1.09 , 6.91]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours [exercise] Favours [ultrasound + ex]
 
 
Analysis 2.7.   Comparison 2: Ultrasound plus exercise versus





Test for overall effect: Z = 18.04 (P < 0.00001)





















IV, Random, 95% CI
37.35 [33.29 , 41.41]
37.35 [33.29 , 41.41]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [exercise] Favours [ultrasound + ex]
 
 
Comparison 3.   Ultrasound versus electrical stimulation





Statistical method Effect size
3.1 Pain (SF-36) short-term 1 39 Mean Difference (IV, Random, 95% CI) 2.50 [-3.67, 8.67]
3.2 Back-specific functional status (Os-
westry) short-term
1 39 Mean Difference (IV, Random, 95% CI) 1.88 [0.00, 3.76]
3.3 Flexion ROM (Schober test) short-
term
1 39 Mean Difference (IV, Random, 95% CI) 0.08 [-0.77, 0.93]
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Test for overall effect: Z = 0.79 (P = 0.43)





















IV, Random, 95% CI
2.50 [-3.67 , 8.67]
2.50 [-3.67 , 8.67]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours [ultrasound] Favours [electrical stim]
 
 
Analysis 3.2.   Comparison 3: Ultrasound versus electrical stimulation,





Test for overall effect: Z = 1.97 (P = 0.05)





















IV, Random, 95% CI
1.88 [0.00 , 3.76]
1.88 [0.00 , 3.76]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours [ultrasound] Favours [electrical stim]
 
 
Analysis 3.3.   Comparison 3: Ultrasound versus electrical





Test for overall effect: Z = 0.18 (P = 0.85)





















IV, Random, 95% CI
0.08 [-0.77 , 0.93]
0.08 [-0.77 , 0.93]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours [electrical stim] Favours [ultrasound]
 
 
Comparison 4.   Ultrasound versus laser





Statistical method Effect size
4.1 Pain (VAS) short-term 1 150 Mean Difference (IV, Random, 95% CI) 0.40 [0.16, 0.64]
4.2 Flexion ROM (Schober test) short-
term
1 150 Mean Difference (IV, Random, 95% CI) 0.48 [0.25, 0.71]
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Test for overall effect: Z = 3.32 (P = 0.0009)





















IV, Random, 95% CI
0.40 [0.16 , 0.64]
0.40 [0.16 , 0.64]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours [ultrasound] Favours [LASER]
 
 





Test for overall effect: Z = 4.10 (P < 0.0001)





















IV, Random, 95% CI
0.48 [0.25 , 0.71]
0.48 [0.25 , 0.71]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours [LASER] Favours [ultrasound]
 
 
Comparison 5.   Ultrasound versus phonophoresis





Statistical method Effect size
5.1 Pain (VAS) short-term 1 40 Mean Difference (IV, Random, 95% CI) 0.10 [-0.68, 0.88]
5.2 Back-specific functional status (Os-
westry) short-term
1 40 Mean Difference (IV, Random, 95% CI) 1.30 [-0.47, 3.07]
5.3 Well-being (general health subscale
of SF-36) short-term
1 40 Mean Difference (IV, Random, 95% CI) -10.75 [-21.83, 0.33]
5.4 Flexion ROM (Schober test) short-
term
1 40 Mean Difference (IV, Random, 95% CI) 0.25 [-0.33, 0.83]
5.5 Trunk flexor strength short-term 1 40 Mean Difference (IV, Random, 95% CI) -0.01 [-0.91, 0.89]
5.6 Trunk flexor endurance short-term 1 40 Mean Difference (IV, Random, 95% CI) 2.10 [-0.70, 4.90]
5.7 Trunk extensor endurance short-
term
1 40 Mean Difference (IV, Random, 95% CI) 33.19 [29.08, 37.30]
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Test for overall effect: Z = 0.25 (P = 0.80)





















IV, Random, 95% CI
0.10 [-0.68 , 0.88]
0.10 [-0.68 , 0.88]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours [phonophoresis] Favours [ultrasound]
 
 
Analysis 5.2.   Comparison 5: Ultrasound versus phonophoresis,





Test for overall effect: Z = 1.44 (P = 0.15)





















IV, Random, 95% CI
1.30 [-0.47 , 3.07]
1.30 [-0.47 , 3.07]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours [ultrasound] Favours [phonophoresis]
 
 
Analysis 5.3.   Comparison 5: Ultrasound versus phonophoresis,





Test for overall effect: Z = 1.90 (P = 0.06)





















IV, Random, 95% CI
-10.75 [-21.83 , 0.33]
-10.75 [-21.83 , 0.33]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [phonophoresis] Favours [ultrasound]
 
 





Test for overall effect: Z = 0.85 (P = 0.40)





















IV, Random, 95% CI
0.25 [-0.33 , 0.83]
0.25 [-0.33 , 0.83]
Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours [phonophoresis] Favours [ultrasound]
 
 
Therapeutic ultrasound for chronic low back pain (Review)









Cochrane Database of Systematic Reviews





Test for overall effect: Z = 0.02 (P = 0.98)





















IV, Random, 95% CI
-0.01 [-0.91 , 0.89]
-0.01 [-0.91 , 0.89]
Mean Difference
IV, Random, 95% CI
-0.5-0.25 0 0.25 0.5
Favours [phonophoresis] Favours [ultrasound]
 
 





Test for overall effect: Z = 1.47 (P = 0.14)





















IV, Random, 95% CI
2.10 [-0.70 , 4.90]
2.10 [-0.70 , 4.90]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [phonophoresis] Favours [ultrasound]
 
 





Test for overall effect: Z = 15.83 (P < 0.00001)





















IV, Random, 95% CI
33.19 [29.08 , 37.30]
33.19 [29.08 , 37.30]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [phonophoresis] Favours [ultrasound]
 
 
Comparison 6.   Ultrasound versus spinal manipulative therapy





Statistical method Effect size
6.1 Pain (VAS) short-term 1 112 Mean Difference (IV, Random, 95% CI) -16.50 [-27.55, -5.45]
6.2 Back-specific functional status
(Oswestry) short-term
1 112 Mean Difference (IV, Random, 95% CI) -7.80 [-13.19, -2.41]
6.3 Flexion ROM short-term 1 112 Mean Difference (IV, Random, 95% CI) -10.00 [-14.37, -5.63]
6.4 Extension ROM short-term 1 112 Mean Difference (IV, Random, 95% CI) -4.00 [-6.77, -1.23]
6.5 Pain (VAS) at 6 months follow-up 1 73 Mean Difference (IV, Random, 95% CI) -15.10 [-32.84, 2.64]
6.6 Back-specific functional status
(Oswestry) at 6 months follow-up
1 73 Mean Difference (IV, Random, 95% CI) -5.20 [-13.05, 2.65]
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Test for overall effect: Z = 2.93 (P = 0.003)





















IV, Random, 95% CI
-16.50 [-27.55 , -5.45]
-16.50 [-27.55 , -5.45]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100





Analysis 6.2.   Comparison 6: Ultrasound versus spinal manipulative





Test for overall effect: Z = 2.83 (P = 0.005)





















IV, Random, 95% CI
-7.80 [-13.19 , -2.41]
-7.80 [-13.19 , -2.41]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10










Test for overall effect: Z = 4.48 (P < 0.00001)





















IV, Random, 95% CI
-10.00 [-14.37 , -5.63]
-10.00 [-14.37 , -5.63]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20










Test for overall effect: Z = 2.83 (P = 0.005)





















IV, Random, 95% CI
-4.00 [-6.77 , -1.23]
-4.00 [-6.77 , -1.23]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
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Analysis 6.5.   Comparison 6: Ultrasound versus spinal





Test for overall effect: Z = 1.67 (P = 0.10)





















IV, Random, 95% CI
-15.10 [-32.84 , 2.64]
-15.10 [-32.84 , 2.64]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [ultrasound] Favours [SMT]
 
 
Analysis 6.6.   Comparison 6: Ultrasound versus spinal manipulative therapy,





Test for overall effect: Z = 1.30 (P = 0.19)





















IV, Random, 95% CI
-5.20 [-13.05 , 2.65]
-5.20 [-13.05 , 2.65]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [ultrasound] Favours [SMT]
 
 
Comparison 7.   Ultrasound versus osteopathic manual treatment




Statistical method Effect size
7.1 Low back pain reduction (threshold >=
30%)
1 233 Risk Ratio (M-H, Random, 95% CI) 0.75 [0.59, 0.95]
 
 
Analysis 7.1.   Comparison 7: Ultrasound versus osteopathic manual






Test for overall effect: Z = 2.43 (P = 0.02)



















M-H, Random, 95% CI
0.75 [0.59 , 0.95]
0.75 [0.59 , 0.95]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours [OMT] Favours [ultrasound]
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Bias domain Source of bias Possible answers
Selection (1) Was the method of randomisation adequate? Yes/No/Unsure
Selection (2) Was the treatment allocation concealed? Yes/No/Unsure
Performance (3) Was the participant blinded to the intervention? Yes/No/Unsure
Performance (4) Was the care provider blinded to the intervention? Yes/No/Unsure
Detection (5) Was the outcome assessor blinded to the intervention? Yes/No/Unsure
Attrition (6) Was the dropout rate described and acceptable? Yes/No/Unsure
Attrition (7) Were all randomised participants analysed in the group to which they had been
allocated?
Yes/No/Unsure
Reporting (8) Are reports of the study free of the suggestion of selective outcome reporting? Yes/No/Unsure
Selection (9) Were the groups similar at baseline regarding the most important prognostic in-
dicators?
Yes/No/Unsure
Performance (10) Were co-interventions avoided or similar? Yes/No/Unsure
Performance (11) Was the compliance acceptable in all groups? Yes/No/Unsure
Detection (12) Was the timing of the outcome assessment similar in all groups? Yes/No/Unsure
Other (13) Are other sources of potential bias unlikely? Yes/No/Unsure




1 A random (unpredictable) assignment sequence. Examples of adequate methods are coin toss (for
studies with 2 groups), rolling a dice (for studies with 2 or more groups), drawing of balls of differ-
ent colours, drawing of ballots with the study group labels from a dark bag, computer-generated
random sequence, preordered sealed envelopes, sequentially ordered vials, telephone call to a
central office, and preordered list of treatment assignments. Examples of inadequate methods are:
alternation, birth date, social insurance/security number, date in which they were invited to partic-
ipate in the study, and hospital registration number.
2 Assignment generated by an independent person not responsible for determining the eligibility of
the patients. This person has no information about the individuals included in the trial and has no
influence on the assignment sequence or on the decision about eligibility of the patient.
3 Index and control groups are indistinguishable for the participants or if the success of blinding was
tested amongst the participants and it was successful.
4 Index and control groups are indistinguishable for the care providers or if the success of blinding
was tested amongst the care providers and it was successful.
5 Adequacy of blinding should be assessed for each primary outcome separately. This item should
be scored 'yes' if the success of blinding was tested amongst the outcome assessors and it was suc-
cessful, or:
Table 2.   Criteria for a judgement of 'yes' for the sources of risk of bias* 
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• for patient-reported outcomes in which the participant is the outcome assessor (e.g. pain, disabil-
ity): the blinding procedure is adequate for outcome assessors if participant blinding is scored
'yes';
• for outcome criteria assessed during scheduled visit and that supposes a contact between partic-
ipants and outcome assessors (e.g. clinical examination): the blinding procedure is adequate if
participants are blinded, and the treatment or adverse effects of the treatment cannot be noticed
during clinical examination;
• for outcome criteria that do not suppose a contact with participants (e.g. radiography, magnetic
resonance imaging): the blinding procedure is adequate if the treatment or adverse effects of the
treatment cannot be noticed when assessing the main outcome;
• for outcome criteria that are clinical or therapeutic events that will be determined by the interac-
tion between participants and care providers (e.g. co-interventions, hospitalisation length, treat-
ment failure), in which the care provider is the outcome assessor: the blinding procedure is ade-
quate for outcome assessors if item 4 (caregivers) is scored 'yes';
• for outcome criteria that are assessed from data of the medical forms: the blinding procedure is
adequate if the treatment or adverse effects of the treatment cannot be noticed on the extracted
data.
6 The number of participants who were included in the study but did not complete the observation
period or were not included in the analysis must be described and reasons given. If the percentage
of withdrawals and dropouts does not exceed 20% for short-term follow-up and 30% for long-term
follow-up and does not lead to substantial bias, a 'yes' is scored (NB these percentages are arbi-
trary, not supported by literature).
7 All randomised participants are reported/analysed in the group to which they were allocated by
randomisation for the most important moments of effect measurement (minus missing values) ir-
respective of non-compliance and co-interventions.
8 All results from all prespecified outcomes have been adequately reported in the published report
of the trial. This information is either obtained by comparing the protocol and the report, or in the
absence of the protocol, assessing that the published report includes enough information to make
this judgement.
9 Groups must be similar at baseline regarding demographic factors, duration and severity of com-
plaints, percentage of participants with neurological symptoms, and value of main outcome mea-
sure(s).
10 If there were no co-interventions, or they were similar between the index and control groups.
11 The review author determines if the compliance with the interventions is acceptable, based on the
reported intensity, duration, number, and frequency of sessions for both the index intervention
and the control intervention(s). For example, physiotherapy treatment is usually administered for
several sessions, therefore it is necessary to assess how many sessions each participant attended.
For single-session interventions (e.g. surgery), this item is irrelevant.
12 Timing of outcome assessment should be identical for all intervention groups and for all primary
outcome measures.
13 Other types of biases. For example:
• when the outcome measures were not valid. There should be evidence from a previous or present
scientific study that the primary outcome can be considered valid in the context of the present;
• industry-sponsored trials. The conflict of interest (COI) statement should explicitly state that the
researchers have had full possession of the trial process from planning to reporting without fun-
ders with potential COI having any opportunity to interfere in the process. If, for example, the sta-
tistical analyses have been done by a funder with a potential COI, usually 'unsure' is scored.
Table 2.   Criteria for a judgement of 'yes' for the sources of risk of bias*  (Continued)
*From Furlan 2015.
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A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL
Last searched 7 January 2020
1 MESH DESCRIPTOR Back Pain EXPLODE ALL AND CENTRAL:TARGET
2 lumb* NEAR pain AND CENTRAL:TARGET
3 lumbago AND CENTRAL:TARGET
4 "back pain" OR backache* AND CENTRAL:TARGET
5 coccyx or coccydynia or sciatic* or spondylosis AND CENTRAL:TARGET
6 MESH DESCRIPTOR Sciatic Neuropathy EXPLODE ALL AND CENTRAL:TARGET
7 MESH DESCRIPTOR Spine EXPLODE ALL AND CENTRAL:TARGET
8 MESH DESCRIPTOR Spinal Diseases EXPLODE ALL AND CENTRAL:TARGET
9 MESH DESCRIPTOR Spinal Fusion EXPLODE ALL AND CENTRAL:TARGET
10 facet NEAR joint* AND CENTRAL:TARGET
11 lumb* NEAR vertebra* AND CENTRAL:TARGET
12 stenosis NEAR spine AND CENTRAL:TARGET
13 stenosis NEAR root AND CENTRAL:TARGET
14 stenosis NEAR spinal AND CENTRAL:TARGET
15 slipped NEAR disc* AND CENTRAL:TARGET
16 slipped NEAR disk* AND CENTRAL:TARGET
17 degenerat* NEAR disc* AND CENTRAL:TARGET
18 degenerat* NEAR disk* AND CENTRAL:TARGET
19 herniat* NEAR disc* AND CENTRAL:TARGET
20 herniat* NEAR disk* AND CENTRAL:TARGET
21 prolaps* NEAR disc* AND CENTRAL:TARGET
22 prolaps* NEAR disk* AND CENTRAL:TARGET
23 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR
#20 OR #21 OR #22 AND CENTRAL:TARGET
24 MESH DESCRIPTOR Ultrasonic Therapy EXPLODE ALL AND CENTRAL:TARGET
25 MESH DESCRIPTOR Ultrasonics EXPLODE ALL AND CENTRAL:TARGET
26 ultrasound OR ultrasonic* AND CENTRAL:TARGET
27 #24 OR #25 OR #26 AND CENTRAL:TARGET
28 #27 AND #23 AND CENTRAL:TARGET
29 (2018 OR 2019 OR 2020):YR AND CENTRAL:TARGET
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30 #28 AND #29 AND CENTRAL:TARGET
March 2018 search in CRS web. Some truncation was revised.
1 MESH DESCRIPTOR Back Pain EXPLODE ALL AND CENTRAL:TARGET
2 lumb* NEAR pain AND CENTRAL:TARGET
3 lumbago AND CENTRAL:TARGET
4 "back pain" or backache* AND CENTRAL:TARGET
5 coccyx or coccydynia or sciatic* or spondylosis AND CENTRAL:TARGET
6 MESH DESCRIPTOR Sciatic Neuropathy EXPLODE ALL AND CENTRAL:TARGET
7 MESH DESCRIPTOR Spine EXPLODE ALL AND CENTRAL:TARGET
8 MESH DESCRIPTOR Spinal Diseases EXPLODE ALL AND CENTRAL:TARGET
9 MESH DESCRIPTOR Spinal Fusion EXPLODE ALL AND CENTRAL:TARGET
10 facet NEAR joint* AND CENTRAL:TARGET
11 lumb* NEAR vertebra* AND CENTRAL:TARGET
12 stenosis NEAR (spine or root or spinal) AND CENTRAL:TARGET
13 slipped NEAR (disc* or disk*) AND CENTRAL:TARGET
14 degenerat* NEAR (disc* or disk*) AND CENTRAL:TARGET
15 herniat* NEAR (disc* or disk*) AND CENTRAL:TARGET
16 displace* NEAR (disc* or disk*) AND CENTRAL:TARGET
17 prolap* NEAR (disc* or disk*) AND CENTRAL:TARGET
18 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17
19 MESH DESCRIPTOR Ultrasonic Therapy EXPLODE ALL AND CENTRAL:TARGET
20 MESH DESCRIPTOR Ultrasonics EXPLODE ALL AND CENTRAL:TARGET
21 ultrasound or ultrasonic* AND CENTRAL:TARGET
22 #19 OR #20 OR #21
23 #18 AND #22
24 #23 AND (2017 TO 2018:YR)
January 2017 search strategy using CRS stand alone. The strategy was revised.
#1 MeSH descriptor: [Back Pain] explode all trees
#2 back pain or backache
#3 (lumb* next pain) or lumbago
#4 coccyx or coccydynia or sciatica or spondylosis
#5 MeSH descriptor: [Sciatic Neuropathy] explode all trees
#6 MeSH descriptor: [Spine] explode all trees
#7 MeSH descriptor: [Spinal Diseases] explode all trees
#8 facet near joint*
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#9 lumb* near vertebra*
#10 MeSH descriptor: [Spinal Fusion] explode all trees
#11 stenosis near (spine or root or spinal)
#12 slipped near (disc* or disk*)
#13 degenerat* near (disc* or disk*)
#14 herniat* near (disc* or disk*)
#15 displace* near (disc* or disk*)
#16 prolap* near (disc* or disk*)
#17 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16
#18 MeSH descriptor: [Ultrasonic Therapy] explode all trees 839
#19 MeSH descriptor: [Ultrasonics] explode all trees 298
#20 ultrasound or ultrasonic*
#21 #18 or #19 or #20
#22 #17 and #21
#23 #22 Publication Year from 2013 to 2017, in Trials
MEDLINE
Last searched 7 January 2020. Line 15 was revised.
1 randomized controlled trial.pt.
2 controlled clinical trial.pt.







10 (animals not (humans and animals)).sh.
11 9 not 10
12 dorsalgia.tw,kf.
13 exp Back Pain/
14 backache.tw,kf.




Therapeutic ultrasound for chronic low back pain (Review)









Cochrane Database of Systematic Reviews










29 11 and 23 and 28
30 limit 29 to yr=2018-2020
31 limit 29 to ed=20180316-20200107
32 30 or 31
Search 16 March 2018. Some truncation was revised.
1 randomized controlled trial.pt.
2 controlled clinical trial.pt.







10 (animals not (humans and animals)).sh.
11 9 not 10
12 dorsalgia.tw,kf.
13 exp Back Pain/
14 backache.tw,kf.




19 exp sciatic neuropathy/
20 spondylosis.tw,kf.
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29 11 and 23 and 28
30 limit 29 to yr=2017-2018
31 limit 29 to ed=20170127-20180316
32 30 or 31
27 January 2017 search strategy. Added line 25 and .tw,kf. fields searched instead of.mp.
1 randomized controlled trial.pt.
2 controlled clinical trial.pt.







10 (animals not (humans and animals)).sh.
11 9 not 10
12 dorsalgia.tw,kf.
13 exp Back Pain/
14 backache.tw,kf.
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29 11 and 23 and 28
30 limit 29 to yr=2013-2017
31 limit 29 to ed=20131010-20170127
32 30 or 31
EMBASE
Last searched 7 January 2020. The RCT filter was revised.
1 Randomized Controlled Trial/
2 exp Controlled Clinical Trial/
3 Controlled Study/
4 Double Blind Procedure/









14 (cross-over or crossover).ti,ab.
15 (compare or compared or comparing or comparison or comparative).ti,ab.
16 ((controlled adj7 study) or (controlled adj7 design)).ti,ab.
17 ((singl* adj7 mask*) or (doubl* adj7 mask*) or (trebl* adj7 mask*) or (tripl* adj7 mask*)).ti,ab.
18 trial.ti,ab.
19 or/1-18
20 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/
21 human/ or normal human/ or human cell/
22 20 and 21
23 20 not 22
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42 24 and 37 and 41
43 limit 42 to yr=2018-2020
44 limit 42 to dd=20180316-20200107
45 43 or 44
Last searched 16 March 2018. Some truncation was revised.
1 Randomized Controlled Trial/
2 exp Controlled Clinical Trial/
3 Controlled Study/
4 Double Blind Procedure/
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13 blind*.ti,ab.
14 (cross-over or crossover).ti,ab.
15 (compare or compared or comparing or comparison or comparative).ti,ab.
16 (controlled adj7 (study or design or trial)).ti,ab.
17 ((singl* or doubl* or trebl* or tripl*) adj7 (blind* or mask*)).ti,ab.
18 trial.ti,ab.
19 or/1-18
20 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/
21 human/ or normal human/ or human cell/
22 20 and 21
23 20 not 22


















42 24 and 37 and 41
43 limit 42 to yr=2017-2018
44 limit 42 to dd=20170127-20180316
45 43 or 44
27 January 2017 search strategy. The RCT filter and line 28 were revised, line 32 was added, and .tw,kw. field was searched instead of.mp.
1 Randomized Controlled Trial/
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2 exp Controlled Clinical Trial/
3 Controlled Study/
4 Double Blind Procedure/









14 (cross-over or crossover).ti,ab.
15 (compare or compared or comparing or comparison or comparative).ti,ab.
16 (controlled adj7 (study or design or trial)).ti,ab.
17 ((singl* or doubl* or trebl* or tripl*) adj7 (blind* or mask*)).ti,ab.
18 trial.ti,ab.
19 or/1-18
20 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/
21 human/ or normal human/ or human cell/
22 20 and 21
23 20 not 22












36 exp Low back pain/
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42 24 and 37 and 41
43 limit 42 to yr=2013-2017
44 limit 42 to dd=20131010-20170127
45 43 or 44
CINAHL
Last searched 7 January 2020. In 2018 some truncations were revised.
S59 S57 OR S58
S58 S56 AND EM 20180316-20200107
S57 S56 Limiters - Published Date: 20180301-20200131
S56 S50 and S55




S51 (MH "Ultrasonic Therapy")
S50 S48 AND S28
S49 S28 and S48
S48 S35 or S43 or S47
S47 S44 or S45 or S46
S46 "lumbago"
S45 (MH "Spondylolisthesis") OR (MH "Spondylolysis")
S44 (MH "Thoracic Vertebrae")
S43 S36 or S37 or S38 or S39 or S40 or S41 or S42
S42 lumb* N2 vertebra*
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S35 S29 or S30 or S31 or S32 or S33 or S34
S34 lumb* N5 pain
S33 lumb* W1 pain
S32 "backache" or back pain
S31 (MH "Low Back Pain")
S30 (MH "Back Pain+")
S29 "dorsalgia"
S28 S26 NOT S27
S27 (MH "Animals")
S26 S7 or S12 or S19 or S25






S19 S13 or S14 or S15 or S16 or S17 or S18
S18 (MH "Prospective Studies+")
S17 (MH "Evaluation Research+")
S16 (MH "Comparative Studies")
S15 latin square 142
S14 (MH "Study Design+")
S13 (MH "Random Sample")




S8 (MH "Placebo EMect")




S3 clinical W3 trial
S2 "randomi?ed controlled trial*"
S1 (MH "Clinical Trials+")
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27 January 2017 search strategy
S59 S57 OR S58
S58 S56 AND EM 20131010-20170127
S57 S56 Limiters - Published Date: 20131001-20170131
S56 S50 and S55




S51 (MH "Ultrasonic Therapy")
S50 S48 AND S28
S49 S28 and S48
S48 S35 or S43 or S47
S47 S44 or S45 or S46
S46 "lumbago"
S45 (MH "Spondylolisthesis") OR (MH "Spondylolysis")
S44 (MH "Thoracic Vertebrae")
S43 S36 or S37 or S38 or S39 or S40 or S41 or S42
S42 lumb* N2 vertebra*






S35 S29 or S30 or S31 or S32 or S33 or S34
S34 lumb* N5 pain
S33 lumb* W1 pain
S32 "backache" or back pain
S31 (MH "Low Back Pain")
S30 (MH "Back Pain+")
S29 "dorsalgia"
S28 S26 NOT S27
S27 (MH "Animals")
S26 S7 or S12 or S19 or S25
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S19 S13 or S14 or S15 or S16 or S17 or S18
S18 (MH "Prospective Studies+")
S17 (MH "Evaluation Research+")
S16 (MH "Comparative Studies")
S15 latin square
S14 (MH "Study Design+")
S13 (MH "Random Sample")




S8 (MH "Placebo EMect")




S3 clinical W3 trial
S2 "randomi?ed controlled trial*"
S1 (MH "Clinical Trials+")
PEDro
Last searched 7 January 2020
Abstract and title: ultrasound AND
Problem: pain AND
Body Part: lumbar spine, sacroiliac joint or pelvis AND
Method: (blank) AND
New records added since: 16/03/2018
Index to Chiropractic Literature (ICL)
Last searched 7 January 2020. In 2018 the search was revised.
S1 Subject:\"Sciatica\" OR Subject:\"Back Pain\" OR Subject:\"Low Back Pain\", Peer Review only
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S2 All Fields:back pain OR All Fields:lumbago OR All Fields:sciatica, Peer Review only
S3 Subject:\"Ultrasonic Therapy\" OR Subject:\"Ultrasonics\", Peer Review only
S4 All Fields:ultrasound OR All Fields:ultrasonic*, Peer Review only
S5 Subject:\"Sciatica\" OR Subject:\"Back Pain\" OR Subject:\"Low Back Pain\", Peer Review only OR All Fields:back pain OR All
Fields:lumbago OR All Fields:sciatica, Peer Review only
S6 Subject:\"Ultrasonic Therapy\" OR Subject:\"Ultrasonics\", Peer Review only OR All Fields:ultrasound OR All Fields:ultrasonic*, Peer
Review only
S7 Subject:\"Sciatica\" OR Subject:\"Back Pain\" OR Subject:\"Low Back Pain\", Peer Review only OR All Fields:back pain OR All
Fields:lumbago OR All Fields:sciatica, Peer Review only AND Subject:\"Ultrasonic Therapy\" OR Subject:\"Ultrasonics\", Peer Review only
OR All Fields:ultrasound OR All Fields:ultrasonic*, Peer Review only
S8, Year: from 2013 to 2017, Peer Review only
S9 Subject:\"Sciatica\" OR Subject:\"Back Pain\" OR Subject:\"Low Back Pain\", Peer Review only OR All Fields:back pain OR All
Fields:lumbago OR All Fields:sciatica, Peer Review only AND Subject:\"Ultrasonic Therapy\" OR Subject:\"Ultrasonics\", Peer Review only
OR All Fields:ultrasound OR All Fields:ultrasonic*, Peer Review only AND, Year: from 2018 to 2020, Peer Review only
ClinicalTrials.gov
Last searched 7 January 2020.
Conditions: back pain AND Other terms: ultrasound
First posted from 03/16/2018 to 01/07/2020
Last searched 16 March 2018.
Conditions: back pain AND Interventions: ultrasound
First posted from 1/27/2017 to 03/16/2018
27 January 2017 search strategy.
Conditions: back pain AND
Interventions: ultrasound
First received from 10/10/2013 to 1/27/2017
ICTRP
Last searched 7 January 2020
Basic search: Back pain AND ultrasound
Appendix 2. The GRADE approach to evidence synthesis
We will categorise the certainty of evidence as follows.
• High (⊕⊕⊕⊕): further research is very unlikely to change the confidence in the estimate of eMect.
• Moderate (⊕⊕⊕⊖): further research is likely to have an important impact in the confidence in the estimate of eMect.
• Low (⊕⊕⊖⊖): further research is very likely to have an important impact on our confidence in the estimate of eMect and is likely to
change the estimate.
• Very low (⊕⊖⊖⊖): any estimate of eMect is very uncertain.
The evidence available to answer each subquestion will be graded on the domains as follows.
1. Risk of bias
Limitations in the study design and implementation may bias the estimates of the treatment eMect. Our confidence in the estimate of the
eMect and in the following recommendation decreases if studies suMer from major limitations. We examined all studies with regard to the
following five types of biases.
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• Selection (random sequence generation, allocation concealment, group similarities at baseline)
• Performance (blinding of participants, blinding of healthcare providers)
• Attrition (dropouts and intention-to-treat analysis)
• Measurement (blinding of the outcome assessors and timing of outcome assessment)
• Reporting bias (selective reporting)
2. Inconsistency
Inconsistency refers to unexplained heterogeneity in results. Widely diMering estimates of the treatment eMect (i.e. heterogeneity or
variability in results) across studies suggest true diMerences in underlying treatment eMect. Inconsistency may arise from diMerences in:
populations (e.g. drugs may have larger relative eMects in sicker populations); interventions (e.g. larger eMects with higher drug doses); or
outcomes (e.g. diminishing treatment eMect with time). We downgraded the certainty of evidence:
• by one level when the heterogeneity or variability in results was large (e.g. I2 > 80%);
• by two levels when the heterogeneity or variability in results was large, and there was inconsistency arising from populations,
interventions, or outcomes.
3. Indirectness
Indirect population, intervention, comparator, or outcome; the question being addressed in this systematic review is diMerent from
the available evidence with regard to the population, intervention, comparator, or an outcome in the included randomised trial. We
downgraded the certainty of evidence:
• by one level when there was indirectness in only one area;
• by two levels when there was indirectness in two or more areas.
4. Imprecision
Results are imprecise when studies include relatively few participants and few events and thus have wide confidence intervals around the
estimate of the eMect. In such a case we downgraded the certainty of the evidence because of consequential uncertainty in the results.
We considered each outcome separately.
For dichotomous outcomes
We considered imprecision for either of the following two reasons.
• There is only one study. When there is more than one study, the total number of events is less than 300 (a threshold rule-of-thumb
value) (Mueller 2007).
• The 95% confidence interval around the pooled or best estimate of eMect includes both: a) no eMect; and b) appreciable benefit or
appreciable harm. The threshold for 'appreciable benefit' or 'appreciable harm' is a relative risk reduction or relative risk increase
greater than 25%.
We downgraded the certainty of evidence:
• by one level when there was imprecision due to either of the above reasons;
• by two levels when there was imprecision due to both of the above reasons.
For continuous outcomes
We considered imprecision for either of the following two reasons.
• There is only one study. When there is more than one study, total population size is less than 400 (a threshold rule-of-thumb value; using
the usual α and β, and an eMect size of 0.2 standard deviations, representing a small eMect).
• The 95% confidence interval includes no eMect, and the upper or lower confidence limit crosses an eMect size (standardised mean
diMerence) of 0.5 in either direction.
We downgraded the certainty of evidence:
• by one level when there was imprecision due to either of the above reasons;
• by two levels when there was imprecision due to both of the above reasons.
5. Publication bias
Publication bias is a systematic underestimate or overestimate of the underlying beneficial or harmful eMect due to the selective
publication of studies. We downgraded the certainty of evidence:
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• by one level when the funnel plot suggested publication bias.
Appendix 3. Therapeutic ultrasound compared with placebo - secondary outcomes
 
Illustrative comparative risks (95% CI)



























The mean flexion ROM
in the control group
for the most repre-
sentative study, Ebadi
2012, is 59.8 mm (SD
17.9).*
The mean flexion ROM
in the intervention
groups was 3.2 mm














culated with an SMD of
0.18 (−0.62 to 0.98).
Estimate is not clinical-









ROM in the control
group for the most
representative study,
Ebadi 2012, is 24.1 mm
(SD 9.3).*
The mean extension
ROM in the interven-
tion groups was 3.1














culated with an SMD of
−0.33 (−0.85 to 0.19).
Estimate is not clinical-
ly important and is very
uncertain.








The mean muscle en-
durance in the control
group was 139.3 sec-
onds.
The mean muscle en-
durance in the inter-
vention group was 11.0












Estimate is not clinical-
ly important and sug-
gests there may be lit-
tle to no difference be-
tween groups.
*Of the trials included in this outcome, we chose the study that is a combination of the most representative study population and the
lowest risk of bias (Ebadi 2012). This figure represents the mean outcome in the control group of this particular study.
CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; ROM: range of motion; SD: standard deviation; SMD:
standardised mean difference
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate certainty: Further research is likely to have an important impact on our confidence in the estimate of effect and may
change the estimate.
Low certainty: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low certainty: We are very uncertain about the estimate.
 
 
1Downgraded one level for unexplained statistical inconsistency (I2 = 64%).
2Downgraded two levels for serious imprecision: small sample size, and the resulting estimate has a wide 95% confidence interval which
includes both potential harm and potential benefit from the intervention.
3Downgraded one level for limitations in study design, two studies at unclear/high risk of selection bias, attrition bias, and reporting bias.
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4Downgraded one level for limitations in study design, one study at unclear risk of selection and reporting bias and high risk of attrition bias.
Appendix 4. Therapeutic ultrasound plus exercise compared with exercise alone - secondary outcomes
 
Illustrative comparative risks (95% CI)
Assumed risk Corresponding risk
Outcomes




















Lumbar flexion range of mo-
tion (ROM)
(Schober test (cm); higher num-
bers mean increased ROM)
Follow-up: short term (post-
treatment)
The mean flexion
ROM in the con-
trol groups ranged
from 0.25 cm to
0.38 cm.
The mean flexion ROM in the
intervention groups was 0.02




















(N·m); higher scores mean in-
creased strength)
Follow-up: short term (post-
treatment)
The mean flex-
or strength in the
control group was
23.2 N·m.
The mean flexor strength in
the intervention group was



















(sit-up test (seconds); higher
numbers mean increased en-
durance)







The mean trunk extensor en-
durance in the intervention
groups was 4.00 seconds




















onds); higher numbers mean in-
creased endurance)







The mean trunk extensor en-
durance in the intervention
groups was 37.35 seconds


















Abbreviations: CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; ROM: range of motion
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate certainty: Further research is likely to have an important impact on our confidence in the estimate of effect and may
change the estimate.
Low certainty: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low certainty: We are very uncertain about the estimate.
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1Downgraded two levels for serious limitations in study design, all studies at unclear/high risk of selection bias, attrition bias, and reporting
bias.
2Downgraded one level for imprecision, small sample size.
W H A T ' S   N E W
 
Date Event Description
7 January 2020 New citation required and conclusions
have changed
The review now includes 10 randomised controlled trials with
updated GRADE ratings; the conclusions have changed as a re-
sult of new included studies. The current evidence remains at
risk of bias; however, there is more certainty of little to no effect
of the intervention.
7 January 2020 New search has been performed New search was performed and methods updated according to
Furlan 2015.
 
H I S T O R Y
Protocol first published: Issue 6, 2011
Review first published: Issue 3, 2014
 
Date Event Description
3 April 2014 New search has been performed One study added as awaiting classification. See Published notes
for details.
 
C O N T R I B U T I O N S   O F   A U T H O R S
Review authors SE, NH, and MvT designed the protocol. SE and NH screened the studies, extracted the data, and performed the analyses.
SE draSed the manuscript with help from the other review authors. All review authors read and approved the final version.
D E C L A R A T I O N S   O F   I N T E R E S T
SE: no conflicts of interest to declare
NH: declares no conflicts of interest. NH works for Cochrane Response, an evidence consultancy initiative from Cochrane, but did not
receive any payment for his contribution to this review.
BF: no conflicts of interest to declare
NNA: no conflicts of interest to declare
MvT: At the time of conducting this systematic review, MvT was a Co-ordinating Editor of the Cochrane Back and Neck Review Group. He
is currently on the Editorial Board and therefore was not part of the peer review or publication decision-making process. Editorial Board
members are required to author reviews to remain current in methods. MvT has also received grants and money to his institution from
the Netherlands Organisation for Health Research and Development and The Dutch Health Insurance Council. He has also received travel,
accommodation, or meeting expenses unrelated to the activities listed from EFIC (European Pain Federation) and the Danish Occupational
Therapy Association. He declares no competing interest; all research funding comes from nonprofit, governmental funding agencies, and
all funding including travel and stay expenses were paid to the Vrije Universiteit.
ABG: no conflicts of interest to declare
EF: no conflicts of interest to declare
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
Adverse events were not listed as an outcome in the protocol, but have been included in this update of the review.
The protocol listed PyscLIT as a database to be searched, but this was removed, and CINAHL, Index to Chiropractic Literature,
ClinicalTrials.gov, and the WHO ICTRP were added as databases since publication of the protocol.
The timing of the outcome measures have been slightly modified from those stated in the protocol to align with recommendations from
Cochrane Back and Neck.
'Risk of bias' assessments are now expressed by domain to align with current methodological recommendations.
The latest version of Review Manager (5.3.5) was used for this update.
Due to the small number of included studies, there were insuMicient data to perform any subgroup or sensitivity analyses. In addition,
funnel plots were not created.
Methods for this review update were revised according to published recommendations from Cochrane Back and Neck (Furlan 2015).
'Summary of findings' tables were created for two main comparisons: therapeutic ultrasound compared to placebo (Summary of findings
1) and therapeutic ultrasound plus exercise compared to exercise alone (Summary of findings 2).
We added additional information on unit of analysis issues with regard to cluster and cross-over trials.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Bias;  Chronic Pain  [*therapy];  Electric Stimulation Therapy;  Exercise Therapy;  Low Back Pain  [*therapy];  Quality of Life;  Randomized
Controlled Trials as Topic;  Ultrasonic Therapy  [adverse eMects]  [*methods]
MeSH check words
Adult; Humans
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